SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One) 

  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2017

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the transition period from to

 

Commission file number 000-54545

 

(Ipsidy) 

 

Ipsidy Inc.

(Exact name of registrant as specified in its charter)

 

(Former Name of Registrant as Specified in its Charter)

 

Delaware   46-2069547
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

 

780 Long Beach Boulevard 

Long Beach, New York
11561 

(Address of principal executive offices) (zip code)

 

407-951-8640 

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 

     Yes       No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files. 

 

    Yes       No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer”, “non-accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated filer             Accelerated filer             
Non-accelerated filer              Smaller reporting company   
(do not check if smaller reporting company)   Emerging growth Company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Indicate the number of shares outstanding of each of the registrant’s classes of common stock as of the latest practicable date. 

 

Class Outstanding at October 31, 2017  
Common Stock, par value $0.0001 364,320,216 shares  
Documents incorporated by reference: None Yes       No 

No

 

 

  

TABLE OF CONTENTS

 

      Page No.
PART I - FINANCIAL INFORMATION
       
Item 1.  Financial Statements.   4 - 7
       
Condensed Consolidated Balance Sheets as of September 30, 2017 (unaudited) and December 31, 2016 4
       
Condensed Consolidated Statements of Operations for the Three and Nine months Ended September 30, 2017 (unaudited) and 2016 (unaudited)   5
       
Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine months Ended September 30, 2017 (unaudited) and 2016 (unaudited)   6
       
Condensed Consolidated Statement of Stockholders’ Equity (Deficit) for the Nine months Ended September 30, 2017 (unaudited)   7
       
Condensed Consolidated Statements of Cash Flows for the Nine months Ended September 30, 2017 (unaudited) and 2016 (unaudited)   8
   
Notes to Unaudited Condensed Consolidated Financial Statements 9-22
       
Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations. 23-28
       
Item 3.  Quantitative and Qualitative Disclosures About Market Risk. 27
       
Item 4.  Controls and Procedures.   27
       
PART II - OTHER INFORMATION
 
Item 1.   Legal Proceedings.   28
       
Item 1A.   Risk Factors.   28
       
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds. 28
       
Item 3.   Defaults Upon Senior Securities. 29
       
Item 4.  Mine Safety Disclosures.   29
       
Item 5.   Other Information.   30
       
Item 6.   Exhibits.   31-37

 

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

 

This report includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Words such as, but not limited to, “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “targets,” “likely,” “aim,” “will,” “would,” “could,” and similar expressions or phrases identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and future events and financial trends that we believe may affect our financial condition, results of operation, business strategy and financial needs. Forward-looking statements include, but are not limited to, statements about:

 

  our lack of significant revenues and history of losses,

  our ability to continue as a going concern,

  our ability to raise additional working capital as necessary,

  our ability to satisfy our obligations as they become due,

  the failure to successfully commercialize our product or sustain market acceptance,

  the reliance on third party agreements and relationships for development of our business,

  the control exercised by our management,

  the impact of government regulation on our business,

  our ability to effectively compete,

  the possible inability to effectively protect our intellectual property,

  the lack of a public market for our securities and the impact of the penny stock rules on trading in our common stock should a public market ever be established.

 

You should read thoroughly this report and the documents that we refer to herein with the understanding that our actual future results may be materially different from and/or worse than what we expect. We qualify all of our forward-looking statements by these cautionary statements including those made in this report, in Part I. Item 1A. Risk Factors appearing in our Annual Report on Form 10-K for the year ended December 31, 2016 and our other filings with the Securities and Exchange Commission. Other sections of this report include additional factors which could adversely impact our business and financial performance. New risk factors emerge from time to time and it is not possible for our management to predict all risk factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Except for our ongoing obligations to disclose material information under the Federal securities laws, we undertake no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events. These forward-looking statements speak only as of the date of this report, and you should not rely on these statements without also considering the risks and uncertainties associated with these statements and our business.

 

OTHER PERTINENT INFORMATION

 

Unless specifically set forth to the contrary, when used in this report the terms “Ipsidy,“ID Global,” the “Company,” “we,” “our,” “us,” and similar terms refers to Ipsidy Inc., a Delaware corporation formerly known as ID Global Solutions Corporation and its subsidiaries. As of February 1, 2017, the Company formally changed its name to Ipsidy Inc.

 

The information which appears on our website www.ipsidy.com is not part of this report.

 

 

 

 ITEM 1. FINANCIAL STATEMENTS

 

IPSIDY INC. AND SUBSIDIARIES 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   September 30,   December 31, 
   2017   2016 
   (Unaudited)     
ASSETS
Current Assets:          
Cash  $1,440,179   $689,105 
Accounts receivable, net   216,921    138,359 
Current portion of net investment in direct financing lease   51,402    44,990 
Inventory   853,647    150,679 
Other current assets   207,938    166,479 
Total current assets   2,770,087    1,189,612 
           
Property and Equipment, net   242,290    115,682 
Other Assets   1,270,876    358,343 
Intangible Assets, net   3,185,416    3,474,291 
Goodwill   6,736,043    6,736,043 
Net Investment in Direct Financing Lease, net of current portion   632,492    674,015 
Total assets  $14,837,204   $12,547,986 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) 
Current Liabilities:          
Accounts payable and accrued expenses  $1,684,377   $1,687,900 
Convertible notes payable, net       250,000 
Derivative liability       8,388,355 
Notes payable, net, current portion       109,819 
Capital lease obligation, current portion   26,614     
Deferred revenue   277,287    398,680 
Total current liabilities   1,988,278    10,834,754 
           
Convertible notes payable, net, less current maturities       2,245,596 
Notes payable, net less current maturities   2,231,648    3,051,603 
Capital lease obligation, net of current portion   122,674     
Derivative liability, net of current portion       9,668,276 
Total liabilities   4,342,600    25,800,229 
           
Commitments and Contingencies (Notes 8 and 12)          
           
Stockholders’ Equity (Deficit):          
Common stock, $0.0001 par value, 1,000,000,000 and 500,000,000 shares authorized; 364,320,216 and 234,704,655 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively   36,432    23,470 
Additional paid in capital   73,646,880    35,341,669 
Accumulated deficit   (63,507,684)   (48,925,993)
Accumulated comprehensive income   318,976    308,611 
Total stockholders’ equity (deficit)   10,494,604    (13,252,243)
Total liabilities and stockholders’ equity (deficit)  $14,837,204   $12,547,986 

 

See notes to condensed consolidated financial statements.

 

4

 

 

IPSIDY INC. AND SUBSIDIARIES  

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 

(Unaudited)

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2017   2016   2017   2016 
Revenues:                
Products and services  $589,576   $576,466   $1,695,737   $1,373,892 
Lease income   18,070    19,735    56,050    33,050 
Total revenues, net   607,646    596,201    1,751,787    1,406,942 
                     
Operating Expenses:                    
Cost of sales   144,367    116,376    448,637    349,034 
General and administrative   2,236,543    2,171,627    10,242,880    10,711,942 
Research and development   6,278    65,582    63,116    387,246 
Depreciation and amortization   99,779    127,473    346,313    388,233 
Total operating expenses   2,486,967    2,481,058    11,100,946    11,836,455 
                     
Loss from operations   (1,879,321)   (1,884,857)   (9,349,159)   (10,429,513)
                     
Other Income (Expense):                    
Gain (loss) on derivative liability       (1,594,636)   (452,146)   16,082,616 
Gain on extinguishment of notes payable           2,802,234     
Loss on modification of derivatives           (319,770)    
Loss on modification of warrants           (158,327)    
Loss on settlement of notes payable           (5,978,643)    
Interest expense   (230,698)   (853,543)   (1,125,880)   (3,126,320)
Other income (expense), net   (230,698)   (2,448,179)   (5,232,532)   12,956,296 
                     
(Loss) income before income taxes   (2,110,019)   (4,333,036)   (14,581,691)   2,526,783 
                     
Income Taxes                
                     
Net (loss) income  $(2,110,019)  $(4,333,036)  $(14,581,691)  $2,526,783 
                     
Net (loss) income Per Share - Basic  $(0.01)  $(0.02)  $(0.04)  $0.01 
                     
Net Loss Per Share - Diluted  $(0.01)  $(0.02)  $(0.04)  $(0.04)
                     
Weighted Average Shares Outstanding - Basic   344,658,454    226,796,302    328,131,720    212,790,554 
                     
Weighted Average Shares Outstanding - Diluted   344,658,454    226,796,302    328,131,720    289,858,911 

 

See notes to condensed consolidated financial statements.

 

5

 

 

IPSIDY INC. AND SUBSIDIARIES 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME  

(Unaudited)

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2017   2016   2017   2016 
                 
Net income (loss)  $(2,110,019)  $(4,333,036)  $(14,581,691)  $2,526,783 
Foreign currency translation (losses) gains   33,685    (18,304)   10,365    102,739 
Comprehensive income (loss)  $(2,076,334)  $(4,351,340)  $(14,571,326)  $2,629,522 

 

See notes to condensed consolidated financial statements.

 

6

 

 

IPSIDY INC. AND SUBSIDIARIES 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) 

(Unaudited)

 

                   Accumulated     
           Additional       Other     
   Common Stock       Paid-in   Accumulated   Comprehensive     
   Shares   Amount   Capital   Deficit   Income   Total 
Balances, December 31, 2016   234,704,655   $23,470   $35,341,669   $(48,925,993)  $308,611   $(13,252,243)
Reclassification of derivatives removal of price protection in warrants           7,614,974            7,614,974 
Issuance of common stock upon conversion of debt and related interest   84,822,006    8,482    21,601,191            21,609,673 
Stock-based compensation           4,891,251            4,891,251 
Common stock issued for services   593,555    60    140,091            140,151 
Common stock issued with note payable   4,500,000    450    841,277            841,727 
Common stock issued for debt issuance costs   1,200,000    120    224,340            224,460 
Common stock issued for cash   20,000,000    2,000    3,998,000            4,000,000 
Cash and common stock issued for equity issuance costs   1,000,000    100    (289,490)           (289,390)
Common stock returned as part of extinguishment of notes payable   (2,500,000)   (250)   (874,750)           (875,000)
Common stock issued for restricted stock   20,000,000    2,000                2,000 
Loss on modification of warrants           158,327              158,327 
Net loss               (14,581,691)       (14,581,691)
Foreign currency translation                   10,365    10,365 
Balances, September 30, 2017   364,320,216   $36,432   $73,646,880   $(63,507,684)  $318,976   $10,494,604 

 

See notes to condensed consolidated financial statements.

 

7

 

  

IPSIDY INC. AND SUBSIDIARIES 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 

(Unaudited)

 

   Nine Months Ended 
   September 30, 
   2017   2016 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income (loss)  $(14,581,691)  $2,526,783 
Adjustments to reconcile net income (loss) with cash flows from operations:          
Depreciation and amortization expense   346,313    388,233 
Stock-based compensation   4,891,251    6,805,776 
Common stock issued for services   140,151    285,227 
Amortization of debt discount   446,410    2,191,786 
Amortization of debt issuance costs   346,651    549,867 
Loss (gain) on derivative liability   452,146    (16,082,616)
Gain on settlement of notes payable   (2,802,234)    
Loss on modification of derivatives   319,770     
Loss on modification of warrants   158,327     
Loss on settlement of debt   5,978,643     
Write off of abandoned product       225,862 
Changes in operating assets and liabilities:          
Accounts receivable   (75,806)   125,814 
Net investment in direct financing lease   35,111    17,845 
Other current assets   (41,459)   (12,929)
Inventory   (704,326)   (159,494)
Accounts payable and accrued expenses   319,814    (401,465)
Deferred revenue   (121,395)   476,457 
Net cash flows from operating activities   (4,892,324)   (3,062,854)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment   (11,392)   (23,309)
Investment in other assets   (921,780)   (136,162)
Cash acquired in acquisition       419,042 
Net cash flows from investing activities   (933,172)   259,571 
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from issuance of notes payable and common stock   3,000,000    1,650,000 
Proceeds from the sale of common stock and other   4,002,000    1,250,000 
Payment of debt and equity issuance costs   (375,821)   (253,642)
Principal payments on notes payable   (59,819)   (60,875)
Principal payments on capital lease obligation   (14,119)    
Net cash flows from financing activities   6,552,241    2,585,483 
           
Effect of Foreign Currencies   24,329    102,739 
           
Net Change in Cash   751,074    (115,061)
Cash, Beginning of the Period   689,105    349,873 
Cash, End of the Period  $1,440,179   $234,812 
           
Supplemental Disclosure of Cash Flow Information:          
Cash paid for interest  $   $ 
Cash paid for income taxes  $   $ 
           
Non-cash Investing and Financing Activities:  $21,609,673   $21,222 
Issuance of common stock for conversion of debt and accrued interest  $   $79,081 
Issuance of common stock in settlment of a contingent liability  $   $59,681 
Reclassification of derivative liabilities upon removal of price protection in warrants  $7,614,974   $692,850 
Issuance of warrants for inventory costs  $224,460   $169,125 
Reclassification of inventory to net investment in direct financing lease  $   $747,944 
Acquisition of equipment pursuant to a capital lease   $163,407   $ 
Issunace of common stock with convertible debt  $   $54,470 
Acquisition of FIN Holdings:          
Issuance of common stock as consideration  $   $9,000,000 
Assumed liabilities       914,218 
Inventory       (112,408)
Accounts receivable       (311,867)
Property and equipment       (100,339)
Intangible assets       (8,970,562)
Cash acquired  $   $419,042 

 

See notes to condensed consolidated financial statements.

 

8

 

 

IPSIDY INC. AND SUBSIDIARIES 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – BASIS OF PRESENTATION

 

In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which we considered as necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (US GAAP have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. The results of operations for the three and nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for future periods or the full year.

 

The condensed consolidated financial statements include the accounts of Ipsidy Inc. and its wholly-owned subsidiaries MultiPay S.A.S., ID Global LATAM S.A.S., IDGS S.A.S., ID Solutions, Inc., Innovation in Motion Inc., FIN Holdings Inc., and Cards Plus Pty Ltd. (the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation.

 

Net Loss per Common Share

 

The Company computes net loss per share in accordance with FASB ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the statement of operations. Basic EPS is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. For the three and nine months ended September 30, 2017, and the three months ended September 30, 2016, all potentially diluted shares were excluded from the calculation of diluted EPS because their impact was anti-dilutive. The following table illustrates the computation of basic and diluted EPS for the nine months ended September 30, 2016:

 

   Net Income   Shares   Per Share Amount 
Basic EPS               
Income available to stockholders  $2,526,783    212,790,554   $0.01 
                
Effect of Dilutive Securities               
Stock Options       17,037,007      
Warrants       21,350,729      
Convertible Debt   (15,533,674)   38,680,621      
Dilute EPS               
Loss available to stockholders plus assumed conversions  $(12,806,891)   289,858,911   $(0.04)

 

9 

 

 

Going concern

 

As of September 30, 2017, the Company had an accumulated deficit of approximately $63.5 million. For the nine months ended September 30, 2017, the Company earned revenue of approximately $1.8 million and incurred a loss from operations of approximately $9.3 million.

 

The reports of our independent registered public accounting firms on our consolidated financial statements for the years ended December 31, 2016 and 2015 contained an explanatory paragraph regarding our ability to continue as a going concern based upon our net losses and accumulated deficits.

 

These condensed consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to meet its obligations and continue its operations for the next fiscal year. The continuation of the Company as a going concern is dependent upon financial support from the Company’s current shareholders, the ability of the Company to obtain additional equity financing to continue operations, the Company’s ability to generate sufficient cash flows from operations, successfully locating and negotiating with other business entities for potential acquisition and /or acquiring new clients to generate revenues and cash flows. As there can be no assurance that the Company will be able to achieve positive cash flows (become profitable) and raise sufficient capital to maintain operations there is substantial doubt about the Company’s ability to continue as a going concern.

 

These condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.

 

Inventories

 

Inventories of kiosks held by IDGS S.A.S are stated at the lower of cost (using the first-in, first-out method) or market. The kiosks will provide electronic ticketing for transit systems. Inventory of plastic/ID cards, digital printing material, which are held by Cards Plus Pty Ltd., are at the lower of cost (using the average method) or market. The Plastic/ID cards and digital printing material are used to provide plastic loyal ID and other types of cards. Inventories as of September 30, 2017 consist of cards inventory and kiosks that have not been placed into service and inventory as of December 31, 2016 consist solely of cards inventory. The Company, in 2017, acquired approximately $707,000 of additional kiosks and components.

 

Leases

 

All leases are classified at the inception as direct finance leases or operating leases based on whether the lease transfers substantially all the risks and rewards of ownership.

 

Leases that transfer to the lessee substantially all of the risks and rewards incidental to ownership of the asset are classified as direct finance leases.

 

Other Assets

 

The increase in other assets is principally due to its continuing investments in its technology platform prior to the respective assets being placed into service.

 

Revenue Recognition

 

Revenue is recognized when persuasive evidence of arrangement exists, delivery has occurred, the fee is fixed or determinable and collectability is probable. Revenue is recognized net of allowances for returns and any taxes collected from customers and subsequently remitted to governmental authorities.

 

Revenue from the sale of unique secure credential products and solutions to customers is recorded at the completion of the project unless the solution benefits to the end user in which additional resources or services are required to be provided.

 

Revenue from club-based services arrangements that allow for the use of hosted software product that are provided on a consumption basis (for example, the number of transactions processed over a period of time) is recognized commensurate with the customer utilization of such resources. Generally, the contract calls for a minimum number of transactions to be charged by the Company monthly. Accordingly, the Company records the minimum transactional fee based on the passage of a month’s time as revenues. Amounts in excess of the monthly minimum, are charged to customers based on the actual number of transactions.

 

Consulting services revenue is recognized as services are rendered, generally based on the negotiated hourly rate in the consulting arrangement and the number of hours worked during the period. Consulting revenue for fixed price services arrangements is recognized as services are provided.

 

10 

 

 

Revenue related to direct financing leases is recognized over the term of the lease using the effective interest method.

 

Income Taxes

 

The Company accounts for income taxes under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740 “Income Taxes.” Under the asset and liability method of FASB ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under FASB ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. For the three and nine months ended September 30, 2017 and 2016, there is no provision for income tax as the Company had a tax loss for United States and foreign activities and all of the Company’s carryforwards are reserved for. The Company’s gain or loss on derivative liability during the nine months ending September 30, 2017 and 2016 is not subject to tax.

 

Recent Accounting Pronouncements

 

On May 28, 2014, the Financial Accounting Standards Board (“FASB”) issued a comprehensive new revenue recognition standard that will supersede nearly all existing revenue recognition guidance under generally accepted accounting principles in the United States. The core principal of the new standard is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The new standard is effective for annual and interim periods beginning after December 15, 2017 and early adoption is permitted. The Company will adopt the new standard on January 1, 2018 and expects to use the modified retrospective approach upon adoption. The Company believes the impact of adopting the new accounting standard will not have a significant impact on its consolidated financial position, results of operations or cash flows. However, the Company’s evaluation of the new standard and the final determination of the impact of the new standard’s adoption is still in progress.

 

In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-04 – Simplifying the Test for Goodwill Impairment, which modified the goodwill impairment test and required an entity to write down the carrying value of goodwill up to the amount by which carrying amount of a reporting unit exceeded its fair value. We have not early adopted this ASU and are currently evaluating the impact on our financial statements.

 

In July 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815). The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. The effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt -Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception. We are currently reviewing the potential impact to the financial statements.

 

11 

 

 

NOTE 2 – INTANGIBLE ASSETS, NET (OTHER THAN GOODWILL)

 

The Company’s intangible assets consist of intellectual property acquired from MultiPay and FIN and are amortized over their estimated useful lives as indicated below. The following is a summary of activity related to intangible assets for the nine months ended September 30, 2017:

 

   Customer Relationships   Intellectual Property   Non-Compete   Patents
Pending
     
Useful Lives  10 Years   10 Years   10 Years   n/a   Total 
Carrying Value at December 31, 2016  $1,446,166   $2,000,858   $8,067   $19,200   $3,474,291 
Additions               9,247    9,247 
Amortization   (119,037)   (176,972)   (2,113)       (298,122)
Carrying Value at September 30, 2017  $1,327,129   $1,823,886   $5,954   $28,447   $3,185,416 

 

The following is a summary of intangible assets as of September 30, 2017:

 

   Customer Relationships   Intellectual Property   Non-Compete   Patent Pending   Total 
Cost  $1,587,159   $2,444,646   $14,087   $28,447   $4,074,339 
Accumulated amortization   (260,030)   (620,760)   (8,133)       (888,923)
Carrying Value at September 30, 2017  $1,327,129   $1,823,886   $5,954   $28,447   $3,185,416 

 

Future expected amortization of intangible assets is as follows for the three-month period remaining in 2017 and the calendar years ending from 2018-2022 and thereafter: 

         
2017       101,927  
2018       407,706  
2019       407,706  
2020       402,109  
2021       398,567  
2022       389,076  
Thereafter       1,078,325  
      $ 3,185,416  

 

NOTE 3 – PROPERTY AND EQUIPMENT, NET

 

Property and equipment consisted of the following as of September 30, 2017 and December 31, 2016:

 

   2017   2016 
Computers and equipment  $197,491   $192,928 
Equipment under capital lease (see note 12)   163,407     
Furniture and fixtures   109,200    109,200 
    470,098   $302,128 
Less Accumulated depreciation   (227,808)   (186,446)
Property and equipment, net  $242,290   $115,682 

 

Depreciation expense totaled $48,191 and $24,029 for the nine months ended September 30, 2017 and 2016, respectively.

 

See Note 11 for equipment amounting to $163,407 acquired pursuant to a capital lease.

 

12 

 

 

NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consisted of the following as of September 30, 2017 and December 31, 2016:

 

    2017     2016  
Trade payables   $ 353,793     $ 341,002  
Accrued interest     295,657       600,624  
Accrued payroll and related liabilites      626,712       421,771  
Other accrued expenses     408,215       324,503  
Total   $ 1,684,377     $ 1,687,900  

 

NOTE 5 - NOTES PAYABLE, NET

 

On January 31, 2017, the Company entered into Conversion Agreements with several accredited investors (the “Investors”) pursuant to which substantially all Investors agreed to convert all amounts of notes payable and convertible notes payable (Note 6) due and payable to such persons including interest under the terms of their respective financing or loan agreement as of January 31, 2017 into shares of Company common stock at $0.10 per share. Certain Investors that had a conversion price less than $0.10 converted at such applicable conversion price. The Conversion Agreements resulted in the conversion of notes and convertible notes amounting to approximately $6,331,000 into 84,822,006 shares of Company common stock with a fair value of approximately $21,610,000. The Investors also agreed to waive any existing rights with respect to certain anti-dilution rights contained in their Stock Purchase Warrants. The Company agreed to reduce the exercise of all outstanding Stock Purchase Warrants acquired as part of a financing or loan that had an exercise price in excess of $0.10 per share to $0.10 per share.

 

As a result of the above agreements associated with the conversion Agreements, the Company recorded a loss on the conversion of debt of approximately $6.0 million (including the effect of the elimination of related conversion feature derivative liabilities – see Note 7), a loss on the modification of warrants of approximately $0.2 million, and a loss on the modification of the derivatives of approximately $0.3 million.

 

On February 22, 2017, the Company entered into an Agreement and Release the (“February 22, 2017 Agreement”) with a holder of certain debentures that will represent final and full payment of all amounts owed under these debentures which include debt with a face value of $300,000, accrued interest of approximately $31,000, cancellation of 3,600,000 warrants previously accounted for as derivative liabilities as well as certain pledged shares (2,500,000 shares) in exchange for $300,000 in cash which was paid in May 2017. As a result of the February 22, 2017 Agreement, the Company recorded a gain on the extinguishment of notes payable of approximately $2.8 million.

 

See notes 6 and 7. 

 

13 

 

 

The following is a summary of notes payable as of September 30, 2017 and December 31, 2016:

 

   2017   2016 
In connection with the acquisition of MultiPay in 2015, the Company assumed three promissory notes. The interest rate was 15.47% per annum. Note was fully repaid in the third quarter of 2017.  $   $46,210 
           
The below section of notes payable were all converted to common stock at $0.10 per share. in connection with the January 2017, conversion agreements described above.          
           
In September 2015, the Company issued 12% notes totaling $973,000. The notes were secured by the assets of the Company, matured in September 2016, and accrued interest was convertible into common stock of the Company at a rate of $0.10 per share.  In connection with the issuance of these notes, the Company also issued warrants for the purchase of 6,486,667 shares of the Company’s common stock at an exercise price of $0.15 per share for a period of five years.  The Company also incurred debt issuance costs of $77,480, which were presented as a discount against the notes and amortized into interest expense over the terms of the notes.       963,000 

 

In October 2015, the Company issued 12% notes in the amount of $225,000. The notes were secured by the assets of the Company, matured in October 2016, and accrued interest was convertible into common stock of the Company at a rate of $0.10 per share.  In connection with the issuance of these notes, the Company also issued warrants for the purchase of 1,500,000 shares of the Company’s common stock at an exercise price of $0.15 per share for a period of five years.  The Company also incurred debt issuance costs of $36,400, which were presented as a discount against the note and amortized into interest expense over the terms of the notes.           225,000  
                 
In November 2015, the Company issued a 12% note in the amount of $25,000. The note was secured by the assets of the Company, matured in October 2016, and accrued interest was convertible into common stock of the Company at a rate of $0.10 per share.  In connection with the issuance of this note, the Company also issued warrants for the purchase of 166,667 shares of the Company’s common stock at an exercise price of $0.15 per share for a period of five years.  The Company also incurred debt issuance costs of $94,400, which was presented as a discount against the note and amortized into interest expense over the term of the note           25,000  
                 
In December 2015, the Company issued 12% notes totaling $850,000. The notes are secured by the assets of the Company and matured in December 2016.  Any unpaid accrued interest on the note is convertible into common stock of the Company at a rate of $0.48 per share.  In connection with the issuance of these notes, the Company also issued warrants for the purchase of 1,770,834 shares of the Company’s common stock at an exercise price of $0.48 per share for a period of five years.  The conversion rate on the accrued interest and the exercise price on the warrants provide the holders with anti-dilution protection that requires these features to be bifurcated and presented as derivative liabilities at their fair values.  See Note 8.           850,000  
                 
In January 2016, the Company issued 12% notes in the amount of $100,000. The note was secured by the assets of the Company, matured in January 2017, and accrued interest was convertible into common stock of the Company at a rate of $0.48 per share. In connection with the issuance of these notes, the Company also issued warrants for the purchase of 208,332 shares of the Company’s common stock at an exercise price of $0.48 per share for a period of five years. The conversion rate on the accrued interest and the warrants provide the holders with anti-dilution protection that requires these features to be bifurcated and presented as derivative liabilities at their fair values. See Note 8.           100,000  
                 
In December 2016, the Company issued promissory notes with an aggregate face value of $1,275,000 which were payable one year from the date of issuance and accrued interest of 10% per annum for the initial nine months of the term of the Notes and 15% per annum for the remaining nine months of the term of the Notes.  The notes holders also received 1,912,500 shares of common stock, with a fair value of $191,250.  The Company allocated the proceeds to the notes and common stock based on their relative fair values, resulting in a discount against the notes for the common stock of $166,304, which was amortized into expense through the date of conversion.  In connection with the issuance of the notes and common stock, the Company also incurred debt issuance costs of $212,427, of which $184,719 was recorded as debt issuance costs against the notes to be amortized over the one-year terms of the notes.           1,275,000  
                 
In November 2016,, the Company issued a 12% promissory note due in January 2017 to an officer and principal stockholder in the amount of $13,609.  In connection with the issuance of this note, the company also issued warrants for the purchase of 1,146,667 shares of the Company’s common stock at an exercise price of $0.15 per share.   This loan was repaid in April 2017.  The note holder also received 20,414, shares of the Company’s common stock with a fair value of $2,041.           13,609  
                 
In January 2017, the Company issued a Senior Unsecured Note with a face value of $3,000,000, payable two years form issuance, along with an aggregate of 4,500,000 shares of Common Stock, with a fair value of $1,147,500.  This loan is due to a Board Member upon his election in September 2017. The Company allocated the proceeds to the common stock based on their relative fair value and recorded a discount of $391,304 to be amortized into interest expense over the two-year term of the note.  The Company also paid debt issuance costs consisting of a cash fee of $120,000 and 1,020,000 shares of common stock of the Company with a fair value of $306,000, of which $208,696 was recorded as debt issuance costs to be amortized into interest expense over the two-year term of the note.     3,000,000        
                 
Total Principal Outstanding   $ 3,000,000     $ 3,497,819  
Unamortized Deferred Debt Discounts     (561,158 )     (159,375 )
Unamortized Deferred Debt Issuance Costs     (207,194 )     (177,022 )
Notes Payable, Net   $ 2,231,648     $ 3,161,422  

 

14 

 

 

The following is a roll-forward of the Company’s notes payable and related discounts for the nine months ended September 30, 2017:

 

   Principal Balance   Debt Issuance Costs  

Debt

Discounts

   Total 
Balance at December 31, 2016  $3,497,819   $(177,022)  $(159,375)  $3,161,422 
New issuances   3,000,000    (310,790)   (841,727)   1,847,483 
Payments   (59,819)           (59,819)
Conversions   (3,438,000)           (3,438,000)
Amortization       280,618    439,944    720,562 
Balance at September 30, 2017  $3,000,000   $(207,194)  $(561,158)  $2,231,648 

 

Future maturities of notes payable are as follows for the three-month period remaining in 2017 and the calendar years ending from 2018-2019:

 

2017  $  
2018      
2019    3,000,000 
    $3,000,000 

 

 15

 

 

NOTE 6 - CONVERTIBLE NOTES PAYABLE, NET

 

See Note 5 for transactions associated with the reduction in convertible notes payable on January 31, 2017.

 

Convertible notes consisted of the following as of September 30, 2017 and December 31, 2016:

 

   2017   2016 
The below section of convertible notes payable were all converted to common stock at $0.10 per share in connection with the January 2017,conversion agreements described in Note 5.
 
In June 2015, the Company issued 10% convertible notes in the aggregate principal amount of $700,000. The notes were secured by the assets of the Company, matured in September 2016, and were convertible into common stock of the Company at a conversion rate of $0.03 per share, subject to adjustment. In connection with the issuance of these notes, the Company also issued warrants for the purchase of 15,400,000 shares of the Company’s common stock at an exercise price of $0.05 per share for a period of five years. The conversion rate on the notes and exercise price of the warrants are subject to adjustment to anti-dilution protection that required these features to be bifurcated and presented as derivative liabilities at their fair values. See Note 7. The Company also incurred debt issuance costs of $124,000, which were presented as a discount against the note and amortized into interest expense over the term of the note.
      $680,000 
           

In July 2015, the Company issued 10% convertible notes with in the aggregate principal amount of $190,000.  The notes are secured by the assets of the Company, matured in July 2016, and are convertible into common stock of the Company at a conversion rate of $0.03 per share, subject to adjustment.  In connection with the issuance of these notes, the Company also issued warrants for the purchase of 4,180,000 shares of the Company’s common stock at an exercise price of $0.05 per share for a period of five years.  The conversion rate on the notes and exercise price of the warrants are subject for adjustment to anti-dilution protection that requires these features to be bifurcated and presented as derivative liabilities at their fair values.  See Note 7. The Company also incurred debt issuance costs of $16,200, which are presented as a discount against the note and amortized into interest expense over the term of the note       166,000 
           
In February 2016, the Company re-issued a 12% convertible note in the amount of $172,095. The note is secured by the assets of the Company, originally maturing in September 2016, and is convertible into common stock of the Company at a rate of $0.10 per share. In connection with the issuance of this note, the Company issued warrants for the purchase of 1,146,667 shares of the Company’s common stock at an exercise price of $0.15 per share for a period of five years.       172,095 
           
In April 2016, the Company issued 12% convertible notes in the amount of $1,550,000. The note is secured by the assets of the Company, matures in October 2016, and is convertible into common stock of the Company at a rate of $0.25 per share.  In connection with the issuance of these notes, the Company also issued warrants for the purchase of 6,200,000 shares of the Company’s common stock at an exercise price of $0.25 per share for a period of five years.  The Company also issued 1,033,337 shares of common stock to the noteholders. The Company also incurred debt issuance costs of $226,400, which are presented as a discount against the note and amortized into interest expense over the term of the note.  In August 2016, the Company entered into an agreement with the April 2016 Investors to reduce the exercise price on the embedded conversion feature and warrants to $0.10 and increase the number of warrants to 15,500,000.  The August 2016 change in the terms of these convertible notes has been determined to be a debt extinguishment in accordance with ASC 470.  The reported amounts under the debt extinguishment are not significantly different than that of the Company’s reported amounts.       1,550,000 
           
Total Principal Outstanding  $   $2,568,095 
Unamortized Discounts – Derivatives       (6,466)
Unamortized Discounts – Debt issuance costs       (66,033)
Convertible Notes, Net  $   $2,495,596 

 

The following is a roll-forward of the Company’s convertible notes and related discounts for the nine months ended September 30, 2017:

 

    Principal
Balance
   Debt Issuance Costs   Debt
Discounts
   Total 
Balance at December 31, 2016   $2,568,095   $(66,033)  $(6,466)  $2,495,596 
Conversions    (2,568,095)           (2,568,095)
Amortization        66,033    6,466    72,499 
Balance at September 30, 2017   $   $   $   $ 

 

 16

 

  

NOTE 7 –DERIVATIVE LIABILITY

 

Due to the potential adjustment in the conversion price associated with certain of the convertible debentures and the potential adjustment in the exercise price of certain of the warrants, the Company had determined that certain conversion features and warrants are derivative liabilities.

 

As described in Note 5 above, the Company on January 31, 2017 entered into Conversion Agreements with Investors pursuant to which each Investors agreed to convert all amounts of debt accrued and payable to such persons including interest under the terms of their respective financing or loan agreement into shares of Company common stock at $0.10 per share. Certain Investors that had a conversion price less than $0.10 converted at such applicable conversion price. The investors at the time of conversion also agreed to waive any existing rights with respect to certain price protection and anti-dilution rights contained in their Stock Purchase Warrants.

 

Additionally, on February 22, 2017, the Company entered into an Agreement and Release with a holder of certain debentures that will represent final and full payment of all amounts owed under such which include debt with a face value of $300,000, accrued interest of approximately $31,000, cancellation of 3,600,000 warrants (previously accounted for as derivative liabilities) as well as certain pledged shares (2,500,000 shares) in exchange for $300,000 in cash. These debentures also had potential price adjustments on these debentures that have also been eliminated.

 

Therefore, as a result of the conversion and repayment of the outstanding indebtedness and related accrued interest as well as the elimination of anti-dilution rights of Stock Purchase Warrants, the Company no longer holds liabilities with derivatives requiring fair value as of September 30, 2017.

 

A summary of derivative activity for the nine months ended September 30, 2017 is as follows:

 

Balance at December 31, 2016   $ 18,056,631  
Modification of derivatives     319,770  
Cancellation of warrants previously accounted for as derivative liabilities and elimination of derivative conversion features resulting from conversion of related party debt to equity     (11,213,573 )
Reclassification of derivatives to equity upon removal of price protection in warrants     (7,614,974 )
Change in fair value     452,146  
Balance at September 30, 2017   $  

 

NOTE 8 – RELATED PARTY TRANSACTIONS

 

Amount Due Officer and Director

 

In November 2016, the Company issued a note payable for $13,609 to one if its Board of Directors and was outstanding at December 31, 2016. The note was repaid in April 2017. In November 2016, the related party also received 20,414 shares of the Company’s common stock with a fair value of $2,041.

 

Convertible Notes Payable

 

On January 31, 2017, the Company entered into Conversion Agreements with Mr. Selzer, a director of the Company and Vista Associates, a family partnership to which Mr. Selzer converted $150,000 in debt plus interest into 1,753,500 shares of common stock and $40,000 of debt plus interest into 1,537,778 shares of common stock.

 

Purchase of Common Stock

 

In March 2017, Mr. Selzer purchased an additional 500,000 shares of common stock of the latest offering as described in Note 9.

 

Other

 

In connection with securing third-party financing, the Company incurred fees to Network 1 Financial Securities, Inc. (“Network 1”), a registered broker-dealer. The Network 1 fees comprise of $360,000 payable in cash and the issuance of 2,200,000 shares of common stock of the Company. A member of the Company’s Board of Directors previously maintained a partnership with a key principal of Network 1. The agreement calls for Network 1 to receive commission, in cash and stock based on the total amount of proceeds from any financing it secures for the Company.

 

 17

 

 

The Company leases it Corporate headquarters from Bridgeworks LLC, (“Bridgeworks”), a company providing office facilities to emerging companies, principally owned by Mr. Beck and his family. Mr. Beck is Chairman, Chief Executive Officer and President of the Company. During the first nine months of 2017, the Company paid Bridgeworks $52,322.

 

The Company entered into a consulting agreement with Graham Beck, a son of Mr. Beck for digital marketing services beginning April 1, 2017 at a rate of $2,500 per month. During the first nine months of 2017, the expense associated with Graham Beck was $15,000.

 

On September 13, 2017, one of the former officers and a former director (Douglas Solomon) of the Company entered into a Confidential Settlement Agreement and General Release (the “Settlement Agreement”) pursuant to which the Offer Letter and Executive Retention Agreement entered between the Company and Mr. Solomon dated January 31, 2017, were terminated effective September 1, 2017 and Mr. Solomon resigned as Executive Director, Government Relations Enterprise Security upon execution of the Settlement Agreement. The Company agreed to pay Mr. Solomon approximately $8,000 representing unused 2017 vacation entitlement and pay for one day, reimburse Mr. Solomon for all expenses consistent with the Company’s reimbursement policy and pay Mr. Solomon’s COBRA employee only benefits through September 2018 if Mr. Solomon elected to be included under such coverage. The parties also provided mutual releases from all claims, demands, actions, causes of action or liabilities. As further consideration for entering into the Settlement Agreement, Mr. Solomon and the Company entered into an Agency Agreement dated September 13, 2017 pursuant to which Mr. Solomon agreed to be engaged as a non-exclusive sales agent for the Company’s products on an as needed basis for a term of three years in consideration of sales commissions including a monthly non-refundable minimum commission to be paid for 24 months. During the quarter ended September 30, 2017, the Company paid Mr. Solomon $13,028 under the terms of such agreement.

 

 18

 

 

NOTE 9STOCKHOLDER’S EQUITY (DEFICIT)

 

Common Stock

 

On September 28, 2017, the stockholders of the Company approved increasing the number of authorized shares of common stock from 500,000,000 to 1,000,000,000.

 

As described in Note 5, on January 31, 2017, in connection with the issuance of a $3,000,000 Senior Unsecured Note, an aggregate of 4,500,000 shares of Common Stock was issued to the Investor and the Company issued Network 1 Financial Securities, Inc. (“Network 1”), a registered broker-dealer, 1,200,000 shares of common stock of the Company in conjunction with its services.

 

As described in Notes 5 and 6, on January 31, 2017, the Company entered into Conversion Agreements with Investors pursuant to which each Investors agreed to convert all amounts of debt accrued and payable to such person including interest under the terms of their respective financing or loan agreement as of January 31, 2017 into shares of Company common stock at $0.10 per shares. The Conversion Agreements resulted in the issuance of an approximately of 84,822,000 shares of Company common stock.

 

On March 22, 2017, the Company entered into Subscription Agreements with several accredited investors (the “March 2017 Accredited Investors”) pursuant to which the March 2017 Accredited Investors agreed to purchase an aggregate of 20,000,000 shares of the Company’s common stock for an aggregate purchase price of $4,000,000. The proceeds were received during 2017. In connection with this private offering, the Company paid Network 1 Financial Securities, Inc. (“Network”), a registered broker-dealer, a cash fee of $240,000 and issued Network 1,000,000 shares of common stock of the Company.

 

Additionally, the Company cancelled certificates for 2,500,000 shares of common stock acquired in conjunction with the purchase of certain debentures.

 

During the nine months ended September 30, 2017, the Company issued approximately 594,000 shares of common stock as consideration for services. The fair value of the shares, totaling approximately $140,000 was estimated based on the publicly quoted trading price and recorded as expense.

  

In connection with the engagement of the CEO and Chief Financial Officer (“CFO”) on January 31, 2017 (the “Grant Date”), the Company agreed to enter into Restricted Stock Purchase Agreements (the “Restricted Shares”) with the CEO and CFO to provide 15,000,000 and 5,000,000 shares of common stock, respectively, at a per share price of $0.0001. On September 29, 2017, and in connection with the increase in the authorized shares, the Company issued the Restricted Shares. The shares are restricted and are not able to be sold or otherwise transferred by the CEO or CFO until such time the Restricted Shares vest. The Restricted Shares vest only upon achieving one of several performances thresholds. As of September 30, 2017, none of the performance thresholds have been met. Accordingly, no compensation expense has been recorded in connection with the issuance of these Restricted Shares. Compensation expense associated with these Restricted Shares will be recorded based on the fair value of the shares on the date it is determined that it is probable that one or more of the performance thresholds will be met in the near term.

 

Warrants

 

As more fully described above the Company agreed to reduce the exercise of all outstanding Stock Purchase Warrants acquired as part of a financing or loan that had an exercise price in excess of $0.10 per share to $0.10 per share.

 

Furthermore, as more fully described above in Note 5, the Company as part of a transaction cancelled 3.6 million warrants.

 

The following is a summary of the Company’s warrant activity for the nine months ended September 30, 2017:

 

      Number of
Shares 
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Life
 
Outstanding at December 31, 2016       51,138,697     $ 0.11       3.8 Years  
Cancelled       (3,600,000 )   $ 0.08       3.9 Years  
Outstanding at September 30, 2017       47,538,697     $ 0.08       2.9 Years  

 

 19

 

 

Stock Options

 

On August 10, 2016, the Company entered into an amended agreement (the “Amendment”) with Parity Labs, LLC (“Parity”) to amend the compensation section of an existing Advisory Agreement previously entered into between the Company and Parity on November 16, 2015 for the provision of strategic advisory services. The Amendment calls for the Company to issue to Parity the option (the “Parity Option”) to acquire 20,000,000 shares of common stock of the Company, exercisable at $0.05 per share for a period of ten years. The Parity Option vests as to 10,000,000 shares of common stock immediately and then in 12 equal tranches of 833,333 shares per month commencing on September 1, 2016. Parity options vested in entirety when Mr. Beck became Chief Executive Officer (“CEO”) of Ipsidy, Inc. in January 2017. Mr. Beck is the manager of Parity.

 

In connection with the engagement of the CEO and Chief Financial Officer (“CFO”) on January 31, 2017, the Company granted the CEO and CFO stock options to acquire 15,000,000 shares and 5,000,000 shares of common stock of the Company respectively at an exercise price of $0.10 per share for a period of ten years. Additionally, the Company granted one employee stock options to acquire 1,000,000 shares of common stock at an exercise price of $0.29 per share for a period of ten years.

 

The Company determined the grant date fair value of the options granted during the Nine months ended September 30, 2017 using the Black Scholes Method and the following assumptions:

 

Expected Volatility – 85%

Expected Term – 5.0 Years

Risk Free Rate – 1.92%

Dividend Rate – 0.00%

 

Activity related to stock options for the nine months ended September 30, 2017 is summarized as follows:

 

      Number of
Shares
    Weighted Average Exercise
Price
    Weighted Average Contractual
Term (Yrs.)
    Aggregate
Intrinsic
Value
 
Outstanding as of December 31, 2016       86,925,000     $ 0.21       9.5     $ 10,023,400  
Granted       21,000,000     $ 0.11       10.0     $  
Forfeitures       (3,425,000 )   $ 0.06       10.0     $  
Outstanding as of September 30, 2017       104,500,000     $ 0.19       9.1     $ 3,989,000  
Exercisable as of September 30, 2017       78,704,170     $ 0.17       8.7     $ 2,788,000  

 

 20

 

 

The following table summarizes stock option information as of September 30, 2017:

 

 Exercise Prices      Outstanding      Weighted
Average
Contractual Life
    Exercisable   
$ 0.0001       3,500,000       8.00 Years       3,500,000  
$ 0.05       33,950,000       8.86 Years       23,312,502  
$ 0.10       27,250,000       9.05 Years       15,583,336  
$ 0.15       6,300,000       7.85  Years       4,258,332  
$ 0.25       500,000       8.50 Years       300,000  
$ 0.29       1,000,000       9.75 Years        
$ 0.40       1,000,000       8.42 Years       1,000,000  
$ 0.45       31,000,000       8.00 Years       30,750,000  
  Total       104,500,000       8.57 Years       78,704,170  

 

Stock option expense for the three and nine months ended September 30, 2017 was approximately $625,000 and $4,892,000, respectively, and for the corresponding periods ended September 30, 2016 was $654,000 and $6,806,000, respectively. The three and nine months ended September 30, 2017, included approximately $61,000 and $1,565,000, respectively of non-employee stock compensation. As of September 30, 2017, there was approximately $3,652,000 of unrecognized compensation costs related to stock options outstanding which will be expensed through 2020.

 

NOTE 10 – DIRECT FINANCING LEASE

 

In September 2015, the Company and an entity in Colombia entered into a rental contract for the rental of 78 kiosks to provide cash collection and fare services at transportation stations. The lease term began in May 2016 when the kiosk were installed and operational and when the lease commenced. The term of the rental contract is ten years at an approximate monthly rental of $11,900. The lease has the option at the end of the lease term to purchase each unit for approximately $40. The term of the lease approximates the expected economic life of the kiosks. The lease was accounted for as a direct financing lease.

 

The Company has recorded the transaction as it’s net investment in the lease and will receive monthly payments of $11,856 before estimated executory costs, or $142,272, annually, to reduce investment in the lease and record income associated with the related amount due. Executory costs are estimated to be $1,677 monthly and initial direct costs are not considered significant. The transaction resulted in incremental revenue in the nine months ended September 30, 2017 of approximately $56,000.

 

 21

 

 

The equipment is subject to direct lease valued at approximately $748,000. At the inception of the lease term, the aggregate minimum future lease payments to be received is approximately $1,422,000 before executory cost. Unearned income is recorded at the inception of this lease was approximately $474,000 and will be recorded over the term of the lease using the effective income rate method. Future minimum lease payments to be received under the lease for the next five years and thereafter are as follows for the three-month period remaining in 2017 and the calendar years ending from 2018-2022 and thereafter: 

       
2017   $ 30,537  
2018     122,145  
2019     122,145  
2020     122,145  
2021     122,145  
2022     122,145  
Thereafter     407,175  
Sub-total     1,048,437  
Less deferred revenue     (364,543 )
Net investment in lease   $ 683,894  

 

NOTE 11 – LEASE OBLIGATION PAYABLE

 

The Company entered into a lease in March 2017 for the rental of its printer for its secured plastic and credential card products business under an arrangement that is classified as a capital lease. The leased equipment is amortized on a straight line basis over its lease term including the last payment (61 payments) which would transfer ownership to the Company. Total amortization related to the lease equipment as of September 30, 2017 is $18.752. The following is a schedule showing the future minimum lease payments under capital lease by year and the present value of the minimum lease payments as of September 30, 2017. The interest rate related to the lease obligation is 12% and the maturity date is March 31, 2022. Future cash payment related to this capital lease are as follow for the three-month period remaining in 2017 and the calendar years ending from 2018-2022 and thereafter. 

       
2017   $ 10,773  
2018     43,096  
2019     43,096  
2020     43,096  
2021     43,096  
2022             10,776  
Total minimum lease payments     193,933  
         
Less: Amount representing interest     44,645  
         
Present value of minimum lease payments   $ 149,288  

   

NOTE 12COMMITMENTS AND CONTINGENCIES

 

Legal Matters

 

From time to time, Company may be involved in legal proceedings in the ordinary course of business, which could result in litigation. While any litigation contains an element of uncertainty, we have no reason to believe that the outcome of such proceedings will have a material adverse effect on the financial condition or results of operations of the Company. 

 

Other

 

The Company entered into an Agency Agreement dated September 13, 2017 pursuant to which a former officer and director agreed to be engaged as a non-exclusive sales agent for the Company’s products on an as needed basis for a term of three years in consideration of sales commissions including a monthly non-refundable minimum commission to be paid for 24 months. The minimum commitment during the term of the agreement is approximately $335,000.

 

In September 2017, the Company entered into a consulting agreement and agency agreement with an organization to provide ongoing business development and marketing analysis/support beginning October 1, 2017 for a period of 24 months but is cancelable at the end of the first year. The minimum commitment for the first year is $180,000 payable monthly at a rate of $15,000. The agreement also provides a one-time payment of $75,000 upon the Company meeting a performance target. The agency agreement provides for additional compensation to be paid upon successful customer acquisition and cash collection from introduced new customers.

 

 22

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The discussion and analysis of our financial condition and results of operations are based on our financial statements, which we have prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenues and expenses during the reporting periods. On an ongoing basis, we evaluate estimates and judgments, including those described in greater detail below. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

As used in this “Management’s Discussion and Analysis of Financial Condition and Results of Operation,” except where the context otherwise requires, the term “we,” “us,” “our,” or “the Company,” refers to the business of Ipsidy Inc. and its subsidiaries.

 

Overview

 

Ipsidy Inc. together with its subsidiaries (the “Company”, “we” or “our”), is a provider of secure, biometric identification, identity management and electronic transaction processing services. In a world that is increasingly digital and mobile, our vision is to enable solutions that provide pre-transaction verification of identity as well as embed identity verification within every electronic transaction message processed through our platform or other electronic systems. We are building upon our existing capabilities in biometric identification and multi-factor identity management solutions to develop an identity transaction platform for our business customers. The platform is being designed to enable the end users of our business customers to more easily authenticate their identity to a mobile phone or portable device of their choosing (as opposed to dedicated hardware). The existing system enables participants to complete transactions with a digitally signed authentication response, including the underlying transaction data and embedded attributes of the participant’s identity.

 

The Company’s products currently focus on the broad requirement for identity, access and transaction verification and associated identity management needs and the requirement for cost-effective and secure mobile electronic payment solutions for institutions and their customers. We aim to offer our customers solutions that can be integrated into each customer’s business operations in order to facilitate their use and enhance the end user customer experience.

 

Management believes that some of the advantages of the Company’s platform approach are the ability to leverage the platform to support a variety of vertical markets including the identity management and transaction processing sectors and the adaptability of the platform to the requirements of new markets and new products requiring low cost, secure, and configurable mobile solutions. These vertical markets include but are not limited to border security, public safety, public transportation, enterprise security payment transactions and banking.

 

The company was incorporated in the State of Delaware on September 21, 2011 and changed its name to Ipsidy Inc. on February 1, 2017, and our common stock is traded on the OTC Markets under the trading symbol “IDGS”. Our corporate headquarters are located at 780 Long Beach Boulevard, Long Beach, NY 11561 and our main phone number is (407) 951-8640. We maintain our website at www.ipsidy.com. The contents of our website are not incorporated into, or otherwise to be regarded as part of this Report on this Quarterly Report on Form 10-Q.

 

 23

 

 

Key Trends

 

We believe that our financial results will be impacted by several market trends in the identity management and transaction processing marketplace, including growing concerns over identity theft and fraud and the increase in electronic payments, solutions provided by non-bank entities. Our results are also impacted by the changes in levels of spending on identity management and security methods, and thus, negative trends in the global economy and other factors which negatively impact such spending may negatively impact the growth our revenue from those products. The global economy has been undergoing a period of political and economic uncertainty and stock markets are experiencing high levels of volatility, and it is difficult to predict how long this uncertainty and volatility will continue.

 

We plan to grow our business by increasing the use of our services by our existing customers, by adding new customers by expanding into new markets and innovation. If we are successful in these efforts, we would expect our revenue to continue to grow. In addition, based on the positive trends in the international payment processing industry noted above, we anticipate that as and when more payments are made using electronic and mobile methods, such as those that we offer, our revenue would also increase. 

 

Going concern

 

As of September 30, 2017, the Company had an accumulated deficit of approximately $63.5 million. For the nine months ended September 30, 2017 the Company earned revenue of approximately $1.8 million and incurred a loss from operations of approximately $9.3 million.

 

The reports of our independent registered public accounting firms on our consolidated financial statements for the years ended December 31, 2016 and 2015 contained an explanatory paragraph regarding our ability to continue as a going concern based upon our net losses.

 

These consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to meet its obligations and continue its operations for the next fiscal year. The continuation of the Company as a going concern is dependent upon financial support from the Company’s current shareholders, the ability of the Company to obtain additional equity financing to continue operations, the Company’s ability to generate sufficient cash flows from operations, successfully locating and negotiating with other business entities for potential acquisition and /or acquiring new clients to generate revenues and cash flows.

 

There is no assurance that the Company will ever be profitable. These condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.

 

Adjusted EBITDA

 

This discussion includes information about Adjusted EBITDA that is not prepared in accordance with GAAP. Adjusted EBITDA is not based on any standardized methodology prescribed by GAAP and is not necessarily comparable to similar measures presented by other companies. A reconciliation of this non-GAAP measure is included below.

 

Adjusted EBITDA is a non-GAAP financial measure that represents GAAP net income (loss) adjusted to exclude (1) interest expense, (2) interest income, (3) provision for income taxes, (4) depreciation and amortization, (5) stock-based compensation expense and (6) certain other items management believes affect the comparability of operating results.

 

Management believes that Adjusted EBITDA, when viewed with our results under GAAP and the accompanying reconciliations, provides useful information about our period-over-period results. Adjusted EBITDA is presented because management believes it provides additional information with respect to the performance of our fundamental business activities and is also frequently used by securities analysts, investors and other interested parties in the evaluation of comparable companies. We also rely on Adjusted EBITDA as a primary measure to review and assess the operating performance of our company and our management, and it will be a focus as we invest in and grow the business. Additionally, we will consider using Adjusted EBITDA in connection with our executive compensation in 2018.

 

Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation from, or as a substitute for, analysis of our results as reported under GAAP. Some of these limitations are:

 

    Adjusted EBITDA does not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments;

 

    Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;

 

    Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements;

 

 24

 

 

    Adjusted EBITDA does not include the impact of certain charges or gains resulting from matters we consider not to be indicative of our ongoing operations.

 

Because of these limitations, adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business. We compensate for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA only as a supplement to our GAAP results.

 

Reconciliation of Net Loss to Adjusted EBITDA 

 

    Three Months Ended     Nine months Ended  
    September 30, 2017     September 30, 2016     September 30, 2017     September 30, 2016  
                                 
Net (loss) gain   $ (2,110,019 )   $ (4,333,036 )   $ (14,581,691 )   $ 2,526,783  
                                 
Add Back:                                
                                 
Interest expense     230,698       853,543       1,125,880       3,126,320  
Conversion of debt, derivative liability, and modifications           1,594,636       4,106,652       (16,082,616 )
Depreciation and amortization     99,779       127,473       346,313       388,233  
Write-off of asset           225,862             225,862  
Taxes                        
Stock compensation     624,581       654,066       4,891,251       6,805,776  
                                 
Adjusted EBITDA (Non-GAAP)   $ (1,154,961 )   $ (877,456 )   $ (4,111,595 )   $ (3,009,642 )

 

The increase in adjusted EBITDA loss in 2017 compared to 2016 is principally due to the Company’s investment in resources required to provide the support for future operations.

 

Three and Nine Months Ended September 30, 2017 and September 30, 2016

 

Revenues, net

 

During the three and nine months ended September 30, 2017, the Company had revenues of approximately $0.6 million and $1.8 million, respectively, compared to $0.6 million and $1.4 million in the three and nine months ended September 30, 2016, respectively. The increase in the nine months ended September 30, 2017 compared to the nine months ended September 30, 2016 is principally related to Cards Plus and ID Solutions which were acquired on February 8, 2016.

 

Cost of sales

 

During the three and nine months ended September 30, 2017, cost of sales were higher than the cost of sales in the three and nine months ended September 30, 2016 due to the revenue increase at Cards Plus which was acquired in February 2016.

 

Operating Expenses

 

During the three month and nine months ended September 30, 2017 general and administrative expenses were $2.3 million and $10.3 million, respectively, compared to general and administrative expenses of $2.2 million and $10.7 million for the three and nine months ended September 30, 2016, respectively. Stock compensation was approximately $.1 million and $1.9 million less in the three and nine months in 2017 compared to 2016. The increase in expenses in 2017 other than the decrease in stock compensation was principally due to higher staff compensation expense and consulting services as resources were added to support the current and future operations.

 

During the nine months ended September 30, 2017, the Company’s research and development expense decreased by approximately $0.3 million as the nine months ended September 30, 2016 included a write-off of certain costs associated with assets being tested which were no longer considered viable.

 

Depreciation and amortization expense remained largely consistent with the three and nine months ended September 30, 2017 compared to September 30, 2016.

 

 25

 

 

Other Income (Expense)

 

Derivative Liability and Net Loss on Modification of Debt

 

The derivative liability is associated with potential adjustments in the conversion price associated with certain convertible debentures and warrants that were used to finance the business. As a result of the valuation of these provisions as of September 30, 2016, the Company experienced an increase in the derivative liability of approximately $1.6 million in the three months and a reduction in the derivative liability of approximately $16.1 million in the nine months. The decline in the derivative liability for the nine months is associated with the lower stock price.

 

During the nine months ended September 30, 2017, the Company performed valuations of the existing liability at the applicable dates as these debentures and warrant terms and conditions were modified and/or eliminated as a result of the Company’s elimination and repayment of certain existing obligations as of January 31, 2017. In the first nine months of 2017, the Company recorded an expense of $0.5 million due to these valuations. Additionally, the Company recorded a gain on the extinguishment of certain notes payable (approximately $2.8 million), and a loss on the modification of derivatives (approximately $.3 million), loss on modification of warrants (approximately $0.2 million), and a loss on the conversion of debt (approximately $6.0 million) (See Notes 5, 6, and 7).

 

Interest expense

 

Interest expense decreased in the three and nine months ended September 30, 2017 compared to the prior year principally due to the debt for equity conversion on January 31, 2017.

 

Liquidity and Capital Resources

 

Liquidity is the ability of a company to generate sufficient cash to satisfy its needs for cash. As of September 30, 2017, the Company had approximately $1.4 million of cash and had $0.8 million of net working capital. Stockholders’ equity was approximately $10.5 million as of September 30, 2017.

 

Cash used in operating activities was approximately $4.9 million in the nine months ended September 30, 2017 compared to $3.1 million in the nine months ended September 30, 2016 as the Company invested in staff and consulting services to support current and future operations.

 

The Company raised $7.0 million of additional financing in the first nine months of 2017. the Company entered into and closed a Securities Purchase Agreement with an accredited investor pursuant to which the Company borrowed $3.0 million on January 31, 2017 in consideration of a Senior Unsecured Note and an aggregate of 4,500,000 shares of Common Stock.  The Senior Unsecured Note matures in January 2019 and bears interest at a rate of 10%. Additionally on March 22, 2017, the Company entered into Subscription Agreements with several accredited investors (the “March 2017 Accredited Investors”) pursuant to which the March 2017 Accredited Investors agreed to purchase an aggregate of 20,000,000 shares of the Company’s common stock for an aggregate purchase price of $4.0 million.

 

We do not have any formal commitments or arrangements for the sales of stock or the advancement or loan of funds at this time other than the amounts detailed in the subsequent events. There can be no assurance that such additional financing will be available to us on acceptable terms, or at all. Our failure to obtain financing would have a material adverse effect on the organization

 

As described in Note 6, on January 31, 2017, the Company converted approximately $6.3 million of debt and accrued interest in 84,822,006 shares of Company’s common stock. All investors that converted their debt and accrued interest to equity also agreed to waive any existing rights with respect to certain anti-dilution rights contained in their Stock Purchase Warrants. The Company agreed to reduce the exercise price of all outstanding Stock Purchase Warrants acquired as part of a financing or loan that had an exercise price in excess of $0.10 per share to $0.10 per share. Additionally, on February 22, 2017, the Company entered into an Agreement and Release (“February 22, 2017 Agreement”) with a holder of certain debentures that will represent final and full payment of all amounts owed under these debentures which include debt with a face value of $300,000, accrued interest of approximately $31,000, cancellation of 3,600,000 warrants previously accounted for as derivative liabilities as well as the right to certain pledged shares in exchange (2,500,000 shares) for $300,000 in cash which was paid in May 2017.

 

The combination of the above events effectively refinanced the Company’s financial position in the first nine months of 2017 and provided the current period financing requirements. The Company anticipates additional financing will be required beyond the current actions and the amounts will be dependent on current operations and investments the Company may pursue. We are expecting to raise capital in the fourth quarter of 2017.

 

 

26 

 

 

Additionally, during the first nine months of 2017, the Company entered into a lease that met the criteria for capitalization and resulted in a capital lease obligation of approximately $161,000 at lease inception. The payments are approximately $43,095 annually during the five year lease term.

 

Off-Balance Sheet Arrangements

 

The Company has no off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is deemed by our management to be material to investors.

 

Recent Accounting Policies

 

The recent material accounting policies that may be the most critical to understanding of the financial results and conditions are discussed in Note 2 of the audited financial statements included in our annual report on form 10-K for the year ended December 31, 2016.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

As a smaller reporting company, we are not required to include disclosure under this item.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

Pursuant to Rules 13a-15(b) and 15-d-15(b) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer of the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this report. The term “disclosure controls and procedures”, as defined under Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Based upon the evaluation of the disclosure controls and procedures at the end of the period covered by this report, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were not effective but improving as a result of continuing weaknesses in its internal control over financial reporting initially identified in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, and as a result of the Company’s March 31, 2017 Form 10-Q amended filing, which are as follows:

 

  - The Company has not established adequate financial reporting monitoring activities to mitigate the risk of management override, specifically because there are few employees and only two officers with management functions and therefore there is lack of segregation of duties.
     
  - An outside consultant assists in the preparation of the annual and quarterly financial statements and partners with the Company to ensure compliance with US GAAP and SEC disclosure requirements.
     
  - Outside counsel assists the Company in the external attorneys to review and editing of the annual and quarterly filings and to ensure compliance with SEC disclosure requirements.

 

In order to address the above material weaknesses, Philip D. Beck, the Chief Executive Officer and President of the Company, and Stuart P. Stoller, the Chief Financial Officer of the Company, who were appointed to such offices on January 31, 2017 have initiated the following actions to remediate the material weaknesses:

 

  - In addition to the engagement of Mr. Beck and Mr. Stoller. who are both experienced public company executives, the Company evaluated its personnel resources and processes and have made certain changes to improve its efficiency and effectiveness in financial reporting.  On August 1, 2017. the Company hired one additional financial resource.

 

27 

 

 

  - The Company continues to use independent consultants and specialists to support its accounting functions which could include the implementation of new accounting standards such as revenue recognition.

 

  - The Compared expanded significantly in 2015 and 2016 as a result of the acquisition of operations in Colombia and South Africa. Due to the Company’s limited human and capital resources, it is in the process of establishing the proper review of the financial reporting and operations of its foreign subsidiaries.

  

  - The Company has taken certain steps to enhance its control environment to promote the adherence to appropriate internal control policies and procedures. These efforts included assessing its levels of analytical reviews among other appropriate steps.

 

  - The Company has and is continuing to reassess and revise key policies and procedures, including the general ledger, general ledger reconciliation, capital expenditure and accounts payable, to develop and deploy effective policies and procedures and reinforced compliance in an effort to constantly improve the Company’s internal control environment.

 

  - The Company has enhanced its internal governance and compliance function by forming committees and it will have periodic and regular meetings to support its internal governance and compliance functions including the formation of a formal audit committee in the 4th quarter of 2017.   

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the quarter ended September 30, 2017 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II

 

ITEM 1. LEGAL PROCEEDINGS

 

We are currently not a party to any material legal or administrative proceedings and are not aware of any pending or threatened material legal or administrative proceedings arising in the ordinary course of business.  We may from time to time become a party to various legal or administrative proceedings arising in the ordinary course of our business.

 

ITEM 1A. RISK FACTORS

 

Risk factors describing the major risks to our business can be found under Item 1A, “Risk Factors”, in our Annual Report on Form 10-K for the year ended December 31, 2016. There has been no material change in our risk factors from those previously discussed in the Annual Report on Form 10-K.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

On January 31, 2017, Mr. Stoller and the Company entered into an Executive Retention Agreement pursuant to which Mr. Stoller agreed to serve as Chief Financial Officer pursuant to which the Company granted Mr. Stoller a Stock Option to acquire 5 million shares of common stock of the Company at an exercise price of $0.10 per share for a period of ten years. Further, upon the Company being legally entitled to do so, the Company has agreed to enter a Restricted Stock Purchase Agreement with Mr. Stoller pursuant to which Mr. Stoller will purchase 5 million shares of common stock at a per share price of $0.0001, which shares of common stock vest upon achieving various milestones. The Stock Options vest with respect to (i) one-third of the shares of common stock upon the one year anniversary of the grant date and (ii) in 24 equal tranches commencing on the one-year anniversary of the grant date.

 

On January 31, 2017, Mr. Beck and the Company entered into an Executive Retention Agreement pursuant to which the Company granted Mr. Beck a Stock Option to acquire 15 million shares of common stock of the Company at an exercise price of $0.10 per share for a period of ten years. Further, upon the Company being legally entitled to do so, the Company has agreed to enter a Restricted Stock Purchase Agreement with Mr. Beck pursuant to which Mr. Beck will purchase 15 million shares of common stock at a per share price of $0.0001, which shares of common stock vest upon achieving various milestones. The Stock Options vest with respect to (i) one-third of the shares of common stock upon January 31, 2017 and (ii) in 24 equal monthly tranches commencing on the grant date. 

 

28 

 

 

On January 31, 2017, the Company entered into Conversion Agreements with several accredited investors (the “Investors”) pursuant to which each of the Investors agreed to convert all amounts of debt accrued and payable to such person including interest under the terms of their respective financing or loan agreement as of January 31, 2017 into shares of Company common stock at $0.10 per share provided that certain Investors that had a conversion price less than $0.10 converted at such applicable conversion price. The Conversion Agreements resulted in the conversion of an aggregate of approximately $6,331,000 into 84,822,006 shares of Company common stock. Certain Investors also agreed to waive any existing rights with respect to certain anti-dilution rights contained in their Stock Purchase Warrants. The Company agreed to reduce the exercise of all outstanding Stock Purchase Warrants acquired as part of a financing or loan that had an exercise price more than $0.10 per share to $0.10 per share. 

 

On January 31, 2017, the Company entered and closed a Securities Purchase Agreement with the Theodore Stern Revocable Trust (the “Stern Trust”) pursuant to which the Stern Trust invested an aggregate of $3 million into the Company in consideration of a Promissory Note (the “Stern Note”) and 4.5 million shares of common stock. The Stern Note is payable two years from the date of issuance and bears interest of 10% per annum, which compounds annually. The Stern Note may be prepaid in whole or in part by the Company at any time without penalty; provided, that any partial payment of principal must be accompanied by payment of accrued interest to the date of prepayment. The Stern Trust may convert interest payable under the Stern Note into shares of common stock of the Company at a conversion price of $0.20 per share. The Company is required to prepay all outstanding principal and accrued but unpaid interest on this Note upon the Company (including any of its subsidiaries) closing on financing that, individually or collectively, generates gross proceeds equal to or more than $15 million. Mr. Stern became a Board Member upon his election in September 2017.

 

 On March 22, 2017, the Company entered into Subscription Agreements with several accredited investors (the “March 2017 Accredited Investors”) pursuant to which the March 2017 Accredited Investors agreed to purchase an aggregate of 20,000,000 shares of the Company’s common stock for an aggregate purchase price of $4,000,000 or a per share price of $0.20. The Company has received proceeds of $3,170,000 as of March 22, 2017. One individual March 2017 Accredited Investor has agreed to fund $830,000, of which $400,000 was received the second quarter of 2017 and the balance will be received in the third quarter of 2017. In connection with this private offering, the Company paid Network 1, a registered broker-dealer, a cash fee of $240,000 and issued Network 1,000,000 shares of common stock of the Company upon increasing its authorized shares of common stock.

 

On January 31, 2017, in connection with the issuance of the Stern Note an aggregate of 4,500,000 shares of Common Stock, the Company issued Network 1, a registered broker-dealer 1,200,000 shares of common stock of the Company in conjunction with its services.

 

On September 29, 2017, the Company issued to the CEO and CFO in connection with their Restricted Stock Purchase Agreements 15,000,000 and 5,000,000 shares of common stock.   

 

During 2017, the Company issued approximately 594,000 shares of common stock issued in consideration of certain technical services.

 

The above offers and sales of the securities were made to accredited investors and the Company relied upon the exemptions contained in Section 4(2) of the Securities Act and/or Rule 506 of Regulation D promulgated there under with regards to the sales. No advertising or general solicitation was employed in offerings the securities. The offers and sales were made to accredited investors and transfer of the securities was restricted by the Company in accordance with the requirements of the Securities Act of 1933.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable to our operations. 

 

29 

 

 

ITEM 5. OTHER INFORMATION

 

Annual Meeting

 

The Company held its Annual Meeting on September 28, 2017 in Long Beach, New York. Of the 336,565,097 shares of Common Stock outstanding on August 29, 2017, the record date, 281,040,309 shares were represented at the Annual Meeting, in person or by proxy, constituting a quorum. The proposals considered at the Annual Meeting are described in detail in the Proxy Statement. The proposals described below were voted upon at the Annual Meeting and the number of votes cast with respect to each proposal was as set forth below:

 

(1) Elect five (5) directors until his successor is duly elected and qualified, or until his earlier death, resignation or removal. The five directors receiving the highest vote were appointed to the board. The following directors were elected to the board.

 

  For Withheld
PHILIP D. BECK 266,299,861 14,740,448
HERBERT SELZER 266,799,861 14,240,448
RICKY SOLOMON 266,299,861 14,740,448
THEODORE STERN 266,799,861 14,240,448
THOMAS SZOKE 276,511,543   4,528,766

 

(2) Ratify the appointment of Cherry Bekaert LLP as the Company’s independent auditors for the fiscal year ending December 31, 2017. This matter was determined based on majority of the shares cast.

 

For Against Abstain
266,799,961 14,240,348 0

 

(3) Approving the 2017 Incentive Stock Plan and to authorize 70,000,000 shares of Common Stock for issuance thereunder. This matter was determined based on majority of the shares cast.

 

For Against Abstain
195,348,041 60,724,008 24,968,260

 

(4) Approving the amendment of the Company’s Certificate of Incorporation to increase the number of authorized shares of common stock from 500,000,000 to 1,000,000,000. This matter was determined based on majority of the shares outstanding.

 

For Against Abstain
232,319,547 48,720,762 0

 

(5) Approving an amendment to our certificate of incorporation to effect a reverse stock split at a ratio not less than 1-for-2 and not greater than 1-for-25, with the exact ratio to be set within that range at the discretion of our board of directors before December 31, 2018 without further approval or authorization of our stockholders. This matter was determined based on majority of the shares cast.

 

For Against Abstain
187,964,609 67,607,440 25,468,260

   

Amendment to the Certificate of Incorporation

 

As detailed above, on September 28, 2017, the stockholders of the Company approved an amendment to the Company’s Certificate of Incorporation, increasing the number of authorized shares of common stock from 500,000,000 to 1,000,000,000. The increase in authorized shares was effected pursuant to a Certificate of Amendment to the Certificate of Incorporation filed with the Secretary of State of the State of Delaware.

 

Other

 

On December 30, 2016, LATAM, a wholly owned subsidiary of the Company, entered into a Contract for the Provision of Cash Collection Services (the “Contract”) with Recaudo Bogota S.A.S. (“RB”), a Colombian company, pursuant to which the Company agreed to supply, maintain and provide platform services for 740 unattended payment collection and fare ticketing kiosks, in consideration of approximately $30 million dollars (excluding VAT) payable over the ten year period of the Contract. The parties are currently re-negotiating the terms of the Contract, including a potential termination of the Contract by mutual consent. There is no guarantee that the parties will be able to enter a definitive agreement pertaining to the re-negotiation or cancellation of the Contract.

 

30 

 

 

ITEM 6. EXHIBITS

 

Exhibit

Number

Description
2.1 (2) Agreement and Plan of Reorganization
     
3.1 (1) Certificate of Incorporation
     
3.2 (1) By-laws
     
3.3 (7) Certificate of Ownership and Merger
     
3.4 (58) Certificate of Amendment to the Certificate of Incorporation dated February 1, 2017
     

3.5

(63)

Certificate of Amendment to the Certificate of Incorporation dated October 3, 2017

     
4.1 (13) Stock Option dated May 28, 2015 issued to Ricky Solomon
     
4.2 (14) Stock Option dated May 28, 2015 issued to Charles D. Albanese
     
4.3 (17) Form of Securities Purchase Agreement by and between ID Global Solutions Corporation and the September 2015 Investors

   

4.4 (18) Form of Security Agreement by and between ID Global Solutions Corporation and the September 2015 Investors
     
4.5 (19) Form of Secured Convertible Debenture issued to the September 2015 Investors
     
4.6 (20) Form of Common Stock Purchase Warrant issued to the September 2015 Investors
     
4.7 (21) Securities Purchase Agreement by and between ID Global Solutions Corporation and Ricky Solomon
     
4.8 (22) Security Agreement by and between ID Global Solutions Corporation and Ricky Solomon
     
4.9 (23) Secured 10% Secured Promissory Note issued to Ricky Solomon
     
4.10 (24) Common Stock Purchase Warrant issued to Ricky Solomon
     
4.11 (25) Form of Securities Purchase Agreement by and between ID Global Solutions Corporation and the 2015 Accredited Investors
     
4.12 (26) Form of Security Agreement by and between ID Global Solutions Corporation and the 2015 Accredited Investors
     
4.13 (27) Form of Secured 12% Secured Promissory Note issued to the 2015 Accredited Investors
     
4.14 (28) Form of Common Stock Purchase Warrant issued to the 2015 Accredited Investors
     
4.15 (29) Stock Option dated September 25, 2015 issued to Herbert M. Seltzer
     
4.16 (30) Letter Agreement by and between ID Global Solutions Corporation and ID Solutions Inc.
     
4.17 (31) Secured 12% Convertible Promissory Note issued to ID Solutions Inc.
     
4.18 (32) Common Stock Purchase Warrant issued to ID Solutions Inc.
     
4.19 (33) Stock Option issued to Thomas Szoke dated September 25, 2015
     
4.20 (34) Stock Option issued to Douglas Solomon dated September 25, 2015
     
4.21 (35) Stock Option issued to Maksim Umarov dated September 25, 2015
     
4.22 (43) Form of Securities Purchase Agreement by and between ID Global Solutions Corporation and the 2015 Accredited Investors
     
4.23 (44) Form of Stock Pledge Agreement by and between ID Global Solutions Corporation and the 2015 Accredited Investors
     
4.24 (45) Form of 12% Promissory Note issued to the 2015 Accredited Investors

 

31 

 

 

4.25 (46) Form of Common Stock Purchase Warrant issued to the 2015 Accredited Investors
     
4.26 (49) Form of Securities Purchase Agreement by and between ID Global Solutions Corporation and the April 2016 Accredited Investors
     
4.27 (50) Form of Stock Pledge Agreement by and between the Affiliates and the April 2016 Accredited Investors
     
4.28 (51) Form of Secured Convertible Debenture issued to the April 2016 Accredited Investors
     
4.29 (52) Form of Common Stock Purchase Warrant issued to the April 2016 Accredited Investors
     
4.30 (53) Form of Securities Purchase Agreement by and between ID Global Solutions Corporation and the December 2016 Accredited Investors
     
4.31 (54) Form of Promissory Note issued to the December 2016 Accredited Investors
     
4.32 (56) Form of Subscription Agreement by and between ID Global Solutions Corporation and the August 2016 Accredited Investors
     
4.33 (56) Form of Letter Agreement entered with the April 2016 Accredited Investors
     
4.34 (56) Stock Option issued to Parity Labs, LLC

  

4.35 (57) Stock Option Agreement entered between the Company and Stuart P. Stoller dated January 31, 2017
     
4.36 (58) Securities Purchase Agreement entered between the Company and the Theodore Stern Revocable Trust dated January 31, 2017
     
4.37 (58) Promissory Note in the principal amount of $3,000,000 payable to the Theodore Stern Revocable Trust
     
4.38 (58) Stock Option Agreement entered between the Company and Philip D. Beck dated January 31 2017
     
4.39 (59) Form of Subscription Agreement by and between Ipsidy Inc and the March 2017 Accredited Investors
     
10.2 (3) Assignment of Patents
     
10.3 (3) Assignment of Patents
     
10.4 (3) Assignment of Patents
     
10.5 (3) Employment Agreement of David Jones
     
10.6 (3) Employment Agreement of Douglas Solomon
     
10.7 (3) Employment Agreement of Thomas Szoke
     
10.8 (3) Promissory Note
     
10.9 (3) Flextronics Manufacturing Services Agreement
     
10.10 (4) Agreement with Tiber Creek Corporation
     
10.11 (4) Adjusted Compensation Agreement David S. Jones through September 30, 2013
     
10.12 (4) Adjusted Compensation Agreement David S. Jones from October 1, 2013
     
10.13 (5) Agreement extending due date of $600,000 Penn Investments Note
     
10.14 (5) Agreement extending due date of $310,000 Penn Investments Note
     
10.15 (5) Promissory Note for $20,000 payable to Penn Investments

 

32 

 

 

10.16 (5) Promissory Note for $180,000 payable to Penn Investments
     
10.17 (6) Note Conversion Agreement dated September 24, 2014 by and between ID Global Corporation and Penn Investments, Inc.
     
10.18 (8) Promissory Note in the principal amount of $17,000 dated August 7, 2014 from Thomas Szoke
     
10.19 (8) Promissory Note in the principal amount of $17,000 dated August 28, 2014 from Thomas Szoke
     
10.20 (9) The ID Global Solutions Corporation Equity Compensation Plan
     
10.21 (10) Real Estate Purchase Agreement dated December 12, 2014 by and between ID Global Solutions Corporation and Megan DeVault and Jeffrey DeLeon
     
10.21(a) (10) Commercial Lease Agreement dated December 19, 2014 by and between ID Global Solutions Corporation and DeLeon-Costa Investments, LLC
     
10.22 (11) Share Purchase Agreement by and between ID Global Solutions Corporation and the Multipay S.A. Shareholders
     
10.23 (12) Form of Share Purchase Agreement by and between ID Global Solutions Corporation and the Multipay S.A. Shareholders
     
10.24 (15) Director Agreement by and between ID Global Solutions Corporation and Ricky Solomon dated May 28, 2015
     
10.25 (16) Executive Employment Agreement by and between ID Global Solutions Corporation and Charles D. Albanese dated May 28, 2015
     
10.26 (25) Rental Contract with Purchase Option by and between ID Global Solutions Corporation and Basetek S.A.S., a Colombian company, dated September 15, 2015

  

10.27 (36) Director Agreement by and between ID Global Solutions Corporation and Herbert M. Seltzer dated September 25, 2015
     
10.28 (37) Director Agreement by and between ID Global Solutions Corporation and Charles Albanese dated September 25, 2015
     
10.29 (38) Employment Agreement between ID Global Solutions Corporation and Maksim Umarov dated July 1, 2015
     
10.30 (39) Letter Agreement entered between ID Global Solutions Corporation and Maksim Umarov dated September 25, 2015
     
10.31 (40) Letter Agreement entered between ID Global Solutions Corporation and Douglas Solomon dated September 25, 2015
     
10.32 (41) Letter Agreement entered between ID Global Solutions Corporation and Thomas Szoke dated September 25, 2015
     
10.33 (48) Share Exchange Agreement by and between ID Global Solutions Corporation, Fin Holdings, Inc. and the Fin Holdings, Inc. shareholders
     
10.34 (55) Contract for the Provision of Cash Collection Services entered into by and between ID Global LATAM S.A.S. and Recaudo Bogota S.A.S. dated December 30, 2016
     
10.35 (57) Confidential Settlement Agreement and General Release between ID Global Solutions Corporation and Charles D. Albanese dated January 26, 2017
     
10.36 (57) Executive Retention Agreement entered between the Company and Stuart P. Stoller dated January 31, 2017
     
10.37 (58) Indemnification Agreement entered between the Company and Stuart P. Stoller dated January 31, 2017

 

33 

 

 

10.38 (58) Executive Retention Agreement entered between the Company and Philip D. Beck dated January 31 2017
     
10.39 (58) Executive Retention Agreement entered between the Company and Thomas Szoke dated January 31 2017
     
10.40 (58) Executive Retention Agreement entered between the Company and Douglas Solomon dated January 31, 2017
     
10.41 (58) Form of Conversion Agreement dated January 31, 2017
     
10.42 (58) Stand-Off Agreement dated January 31, 2017 entered between Philip Beck, Stuart Stoller, Thomas Szoke, Douglas Solomon, Herbert Selzer, Ricky Solomon and the Company
     
10.43 (60) Amendment No. 1 to the Share Purchase Agreement by and between Ipsidy Inc and the MultiPay Shareholders dated March 7, 2105
     
10.44 (58) Form of Indemnity Agreement
     
10.45 (62) Confidential Settlement Agreement and General Release between Ipsidy Inc. and Douglas Solomon dated September 13, 2017
     
10.46 (62) Agency Agreement between Ipsidy Inc. and Douglas Solomon dated September 13, 2017
     
10.47   Restricted Stock Agreement dated September 29, 2017 between Philip D. Beck and Ipsidy Inc.
     
10.48  

Restricted Stock Agreement dated September 29, 2017 between Stuart P. Stoller and Ipsidy Inc. 

     
14.1  (61) Code of Ethics
     
21.1  (61) List of Subsidiaries
     
31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act*
     
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act
     
32.1   Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

101.INS XBRL Instance Document *

101.SC XBRL Taxonomy Extension Schema Document *

101.CA XBRL Taxonomy Extension Calculation Linkbase Document *

L

101.DEF XBRL Taxonomy Extension Definition Linkbase Document *

101.LA XBRL Taxonomy Extension Label Linkbase Document *

B

101.PRE XBRL Taxonomy Extension Presentation Linkbase Document *

 

* Filed herein

 

(1)            Previously filed on Form 10-12G on November 9, 2011 (File No.: 000-54545) as the same exhibit number as the exhibit number listed here, and incorporated herein by this reference.

 

(2)            Previously filed on Form 8-K on August 13, 2013 (File No.: 000-54545) as the same exhibit number as the exhibit number listed here, and incorporated herein by this reference.

 

(3)            Previously filed on Form S-1 on February 13, 2014 (File No.: 333-193924), as amended, as the same exhibit number as the exhibit number listed here, and incorporated herein by this reference.

 

(4)            Previously filed on Form S-1 on September26, 2014 (File No.: 333-193924), as amended, as the same exhibit number as the exhibit number listed here, and incorporated herein by this reference

 

34 

 

 

(5)            Previously filed on Form S-1 on August 12, 2014 (File No.: 333-193924), as amended, as the same exhibit number as the exhibit number listed here, and incorporated herein by this reference

 

(6)            Previously filed on Form 8-K on September 25, 2014 (File No.: 000-54545) as the same exhibit number as the exhibit number listed here, and incorporated herein by this reference.

 

(7)            Previously filed on Form 8-K on October 9, 2014 (File No.: 000-54545) as the same exhibit number as the exhibit number listed here, and incorporated herein by this reference.

 

(8)            Previously filed on Form 10-Q on November 14, 2014 (File No.: 000-54545) as the same exhibit number as the exhibit number listed here, and incorporated herein by this reference.

 

(9)            Previously filed on Form 8-K on November 28, 2014 (File No.: 000-54545) as the same exhibit number as the exhibit number listed here, and incorporated herein by this reference.

 

(10)          Previously filed on Form 8-K on December 22, 2014 (File No.: 000-54545) as the same exhibit number as the exhibit number listed here, and incorporated herein by this reference.

 

(11)          Previously filed on Form 8-K on March 12, 2015 (File No.: 000-54545) and incorporated herein by this reference.

 

(12)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on March 12, 2015.

 

(13)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on September1, 2015.

 

(14)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on September1, 2015.

 

(15)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on September1, 2015.

 

(16)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on September1, 2015.

 

(17)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on July 2, 2015.

  

(18)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on July 2, 2015.

 

(19)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on July 2, 2015.

 

(20)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on July 2, 2015.

 

(21)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on September 9, 2015.

 

(22)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on September 9, 2015.

 

(23)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on September 9, 2015.

 

(24)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on September 9, 2015

 

(25)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on September 22, 2015.

 

(26)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

35 

 

 

(27)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(28)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(29)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(30)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(31)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(32)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(33)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(34)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(35)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(36)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(37)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(38)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(39)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(40)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(41)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(42)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 1, 2015.

 

(43)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on December 29, 2015.

 

(44)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on December 29, 2015.

 

(45)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on December 29, 2015.

  

(46)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on December 29, 2015.

 

36 

 

 

(47)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on January 8, 2016.

 

(48)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on February 12, 2016.

 

(49)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on April 25, 2016.

 

(50)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on April 25, 2016.

 

(51)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on April 25, 2016.

 

(52)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on April 25, 2016.

 

(53)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on December 28, 2016.

 

(54)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on December 28, 2016.

 

(55)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on January 6, 2017.

 

(56)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on August 16, 2016.

 

(57)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on February 1, 2017.

 

(58)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on February 6, 2017.

 

(59)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on March 23, 2017.

 

(60)          Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities Exchange Commission on March 31, 2017.

 

(61)          Incorporated by reference to the Form 10-K Annual Report filed with the Securities Exchange Commission on July 12, 2017.

 

(62)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on September 14, 2017

 

(63)          Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 3, 2017

 

37 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Ipsidy Inc.
   
  By: /s/ Philip Beck
 

Philip Beck, Chairman of the Board of Directors, Chief Executive Officer,

and President

  Principal Executive Officer
   
  By: /s/ Stuart Stoller
  Chief Financial Officer,
  Principal Financial and Accounting Officer
   
Dated: November 13, 2017  

 

38 

 


 Exhibit 10.47

 

IPSIDY INC.

 

RESTRICTED STOCK AGREEMENT

 

This Restricted Stock Agreement (the “Agreement”) is made and entered into as of September 29, 2017 (the “Effective Date”) by and between Ipsidy Inc., a Delaware corporation (the “Company”), and the purchaser named below (the “Purchaser”).

 

Name of Purchaser Total Number of Shares Purchase Price Per Share Total Purchase Price
Philip Beck 15,000,000 $0.0001 $1,500.00

 

1.             PURCHASE OF SHARES.

 

1.1           Purchase of Shares. On the Effective Date and subject to the terms and conditions of this Agreement, Purchaser hereby purchases from the Company, and the Company hereby sells to Purchaser, the Total Number of Shares set forth above (the “Shares”) of the Company’s Common Stock, $0.0001 par value per share, at the Purchase Price Per Share as set forth above (the “Purchase Price Per Share”) for a Total Purchase Price as set forth above (the “Purchase Price”). As used in this Agreement, the term “Shares” includes the Shares purchased under this Agreement and all securities received (a) in replacement of the Shares, (b) as a result of stock dividends or stock splits with respect to the Shares, and (c) in replacement of the Shares in a merger, recapitalization, reorganization or similar corporate transaction.

1.2           Payment. Company hereby agrees to make payment of the Purchase Price on behalf of Purchaser by way of bonus payment, receipt of which is acknowledged by the Company.

 

2.            COMPANY’S REPURCHASE OPTION FOR UNVESTED SHARES. The Company, or its assignee, shall have the option to repurchase all or a portion of the Purchaser’s Unvested Shares (as defined below) on the terms and conditions set forth in this Section (the “Repurchase Option”) in the event of Purchaser’s termination for any reason whatsoever except in the event of Termination Upon Change of Control (as defined in the Executive Retention Agreement entered into between Company and Purchaser on the date hereof (“Retention Agreement”).

 

2.1           Termination and Termination Date. In case of any dispute as to whether Purchaser is terminated, the Board of Directors of the Company or any Compensation Committee of the Board if such then exists (the “Board”) shall have discretion to determine whether Purchaser has been terminated and the effective date of such termination (the “Termination Date”).

 

2.2           Vested and Unvested Shares. Shares that are vested pursuant to the schedule set forth in this Section 2.2 are “Vested Shares. Shares that are not vested pursuant to such schedule are Unvested Shares.

 

2.2.1       Vesting of Shares. On the Effective Date all of the Shares will be Unvested Shares (the “Unvested Shares”). If Purchaser has continuously provided services to the Company (which shall include for this purpose any subsidiary or parent of the Company), whether as an employee, director, officer or consultant at all times from the Effective Date to the date upon which any of the applicable “Performance Goals” set forth in the schedule below (the “Performance Based Vesting Schedule”) are achieved (such date the “Performance Date”), the “Number of Unvested Shares Becoming Vested Shares” on such Performance Date shall become Vested Shares upon written certification by the Board that the corresponding “Performance Goal” as set forth in the Performance Based Vesting Schedule have been satisfied; provided that such Performance Date occurs on or prior to the last day of the applicable “Performance Period” specified in the Performance Based Vesting Schedule. The Board shall make all such determinations with respect to the achievement and timing of the Performance Goal within the applicable Performance Period. Notwithstanding the foregoing, any Unvested Shares that do not become Vested Shares within the applicable Performance Period shall be forfeited and may be repurchased pursuant to Section 2.3 hereof.

 

-1-

 

 

Performance Based Vesting Schedule

 

A.            Performance Goal

 

(1) the occurrence of a Change of Control, (as defined below); OR

 

(2) the filing of Company’s Annual Report on Form 10K in any year, which Report shows that the Company has achieved Adjusted EBITDA for the year, as reported therein, which is not less $10,000,000; OR

 

(3) the Company’s shares becoming listed on a national securities exchange AND (x) if the Board determines that additional equity funding is required, the Company’s closing (whether at the time of listing or subsequent thereto) of a public offering of its equity, raising not less than $10,000,000 in gross proceeds in the aggregate, AND (y) the Company achieving a valuation of not less than $125,000,000 which shall be satisfied either by the closing of the aforementioned public offering with an offering price which equates to a valuation of the Company, which is not less than $125,000,000; or the Company’s shares achieving a closing price on such exchange on 10 trading days out of a period of 30 days, which when multiplied by the number of issued and outstanding shares of Common Stock which are so listed at such time equate to a market capitalization of the Company of not less than $125,000,000; OR

 

(4) the filing of an Annual Report on Form 10K, or a Quarterly Report on Form 10Q, showing that the Company has generated total revenue of not less than $20,000,000 during the 12 month period ending with the period to which the relevant report relates. If such conditions are fulfilled, or waived by the Board, the above bonus shall be payable with the next payroll following the occurrence of the relevant event, subject to all applicable deductions required by law.

 

“Change of Control” shall mean (1) the Company is party to a merger or consolidation, or series of related transactions, which results in the voting securities of the Company outstanding immediately prior thereto failing to continue to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity), directly or indirectly, at least fifty (50%) percent of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; OR (2) the sale or disposition of all or substantially all of the Company’s assets, or consummation of any transaction, or series of related transactions, having similar effect (other than to a subsidiary of the Company)

 

B.            Expiration Date of Performance Period: The Termination Date

C.            Number of Unvested Shares Becoming Vested Shares: 15,000,000

 

If the number of outstanding common shares is changed by a stock dividend, recapitalization, stock split, reverse stock split, subdivision, combination, reclassification or similar change in the capital structure of the Company, without consideration, then the number of Shares subject to this Agreement, the number of Shares, and all other performance criteria set forth in this Section 2.2.1 will be equitably and proportionately adjusted, subject to any required action by the Board or the stockholders of the Company and compliance with applicable securities laws; provided that fractions of a Share will not be issued but will either be replaced by a cash payment equal to the Fair Market Value (as defined below) of such fraction of a Share or will be rounded up to the nearest whole Share, as determined by the Board.

 

-2-

 

 

2.3         Exercise of Repurchase Option. At any time within ninety (90) days after the Purchaser’s Termination Date or the Expiration Date of the Performance Period, the Company, or its assignee, shall repurchase any or all the Purchaser’s Unvested Shares by giving Purchaser written notice of exercise of the Repurchase Option, specifying the number of Unvested Shares to be repurchased. Such Unvested Shares shall be repurchased at the price of $1 in the aggregate (the “Repurchase Price”).

 

2.4         Right of Termination Unaffected. Nothing in this Agreement shall be construed to limit or otherwise affect in any manner whatsoever the right or power of the Company (or any Parent or Subsidiary of the Company) to terminate Purchaser’s employment or other relationship with Company (or the Parent or Subsidiary of the Company) at any time, for any reason or no reason, with or without cause.

 

3.            REPRESENTATIONS AND WARRANTIES OF PURCHASER. Purchaser represents and warrants to the Company as follows.

 

3.2           Access to Information. Purchaser has had access to all information regarding the Company and its present and prospective business, assets, liabilities and financial condition that Purchaser reasonably considers important in making the decision to purchase the Shares, and Purchaser has had ample opportunity to ask questions of the Company’s representatives concerning such matters and this investment.

 

3.3           Understanding of Risks. Purchaser is fully aware of: (a) the highly speculative nature of the investment in the Shares; (b) the financial hazards involved; (c) the lack of liquidity of the Shares and the restrictions on transferability of the Shares (e.g., that Purchaser may not be able to sell or dispose of the Shares or use them as collateral for loans); (d) the qualifications and backgrounds of the management of the Company; and (e) the tax consequences of investment in the Shares.

 

3.4           Purchase for Own Account for Investment. Purchaser is purchasing the Shares for Purchaser’s own account for investment purposes only and not with a view to, or for sale in connection with, a distribution of the Shares within the meaning of the Securities Act. Purchaser has no present intention of selling or otherwise disposing of all or any portion of the Shares and no one other than Purchaser has any beneficial ownership of any of the Shares.

 

3.5           No General Solicitation. At no time was Purchaser presented with or solicited by any publicly issued or circulated newspaper, mail, radio, television or other form of general advertising or solicitation in connection with the offer, sale and purchase of the Shares.

3.6           SEC Rule 144. Purchaser has been advised that SEC Rule 144 promulgated under the Securities Act, which permits certain limited sales of unregistered securities, may be available with respect to the Shares and, in any event, requires that the Shares be held for a minimum of six (6) months, and in certain cases one (1) year, after they have been purchased and paid for (within the meaning of Rule 144). Purchaser understands that Rule 144 may indefinitely restrict transfer of the Shares so long as Purchaser remains an “affiliate” of the Company or if “current public information” about the Company (as defined in Rule 144) is not publicly available.

 

4.            ADDITIONAL RESTRICTIONS UPON SHARE OWNERSHIP OR TRANSFER.

 

4.1           Rights as a Stockholder. Subject to the terms and conditions of this Agreement, Purchaser will have all of the rights of a stockholder of the Company with respect to the Shares from and after the date that Shares are issued to Purchaser until such time as Purchaser disposes of the Shares or the Company and/or its assignee(s) exercise(s) the Repurchase Option except the right to receive cash distributions or dividends, which to the extent the same are declared shall be held in escrow by the Company and shall only be paid if and to the extent that the Shares become Vested Shares. Upon exercise of the Repurchase Option, Purchaser will have no further rights as a holder of the Shares so purchased upon such exercise, other than the right to receive payment for the Shares so purchased in accordance with the provisions of this Agreement.

 

-3-

 

 

4.2           Legends. Unless and until the Shares become Vested Shares and are registered under the Securities Act, all certificates representing the Shares and any certificates subsequently issued in substitution therefor and any certificate for any securities issued pursuant to any stock split, share reclassification, stock dividend or other similar capital event shall bear legends in substantially the following form:

 

THESE SECURITIES ARE SUBJECT TO A RESTRICTED STOCK AGREEMENT BETWEEN THE STOCKHOLDER AND THE COMPANY WHICH CONTAINS RESTRICTIONS ON TRANSFER AND HAVE NOT BEEN REGISTERED OR OTHERWISE QUALIFIED UNDER THE SECURITIES ACT OF 1933 (THE ‘SECURITIES ACT’) OR UNDER THE APPLICABLE OR SECURITIES LAWS OF ANY STATE. NEITHER THESE SECURITIES NOR ANY INTEREST THEREIN MAY BE SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF WITHOUT THE CONSENT OF THE COMPANY AND IN THE ABSENCE OF REGISTRATION UNDER THE SECURITIES ACT OR ANY APPLICABLE SECURITIES LAWS OF ANY STATE, UNLESS PURSUANT TO EXEMPTIONS THEREFROM.

 

and/or such other legend or legends as the Company and its counsel deem necessary or appropriate. Appropriate stop transfer instructions with respect to the Shares have been or may be placed with the Company’s transfer agent.

 

4.3           Encumbrances on Shares. Purchaser may not grant a lien or security interest in, or pledge, hypothecate or encumber, any Unvested Shares.

 

4.4           Restrictions on Transfers. Unvested Shares may not be sold or otherwise transferred by Purchaser without the Company’s prior written consent. Notwithstanding the foregoing, Purchaser shall be able to transfer the Shares, whether or not Vested Shares, for bona fide estate planning purposes to a person or to an entity that constitutes an Authorized Transferee. Subject to Company’s insider trading and other related policies, Purchaser hereby agrees that Purchaser shall make no disposition of the Shares (other than as permitted by this Agreement) unless and until:

 

(a)            Purchaser shall have notified the Company of the proposed disposition and provided a written summary of the terms and conditions of the proposed disposition;

 

(b)            Purchaser shall have complied with all requirements of this Agreement applicable to the disposition of the Shares, including the Repurchase Option; and

 

(c)            Purchaser shall have provided the Company with written assurances, in form and substance satisfactory to counsel for the Company, that (i) the proposed disposition does not require registration of the Shares under the Securities Act or under any state securities laws, and (ii) all appropriate actions necessary for compliance with the registration and qualification requirements of the Securities Act and any state securities laws, or of any exemption from registration or qualification, available thereunder (including Rule 144) have been taken.

 

Each person (other than the Company) to whom the Shares are transferred by means of one of the permitted transfers specified in this Agreement must, as a condition precedent to the validity of such transfer, acknowledge in writing to the Company that such person is bound by the provisions of this Agreement and that the transferred Shares are subject to the Repurchase Option granted hereunder, to the same extent such Shares would be so subject if retained by the Purchaser or otherwise determined by the Board.

 

-4-

 

 

4.5           Stop-transfer Orders. Purchaser understands and agrees that to ensure compliance with the restrictions imposed by this Agreement, the Company may issue appropriate “stop-transfer” instructions to its transfer agent. The Company will not be required (a) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or (b) to treat as owner of such Shares, or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares have been so transferred.

 

5.            TAX WITHOLDING AND TAX CONSEQUENCES. The Company may withhold federal, state, local and foreign taxes as required and permitted by applicable law and is authorized to withhold from Shares otherwise deliverable to Purchaser upon vesting that number of Shares having a Fair Market Value determined as of the date of withholding equal to the minimum amount required to be withheld. PURCHASER UNDERSTANDS THAT PURCHASER MAY SUFFER ADVERSE TAX CONSEQUENCES AS A RESULT OF PURCHASER’S PURCHASE OR DISPOSITION OF THE SHARES. PURCHASER REPRESENTS (a) THAT PURCHASER HAS CONSULTED WITH ANY TAX ADVISER THAT PURCHASER DEEMS ADVISABLE IN CONNECTION WITH THE PURCHASE OR DISPOSITION OF THE SHARES AND (b) THAT PURCHASER IS NOT RELYING ON THE COMPANY FOR ANY TAX ADVICE.

 

5.1           Section 83(b) Election. Purchaser hereby acknowledges that Purchaser has been informed that, with respect to Unvested Shares, unless an election is filed by Purchaser with the Internal Revenue Service (and, if necessary, the proper state taxing authorities) within 30 days after the purchase of the Shares electing, pursuant to Section 83(b) of the Internal Revenue Code (and similar state tax provisions, if applicable), to be taxed currently on any difference between the Purchase Price of the Unvested Shares and their Fair Market Value on the date of purchase, there will be a recognition of taxable income to Purchaser, measured by the excess, if any, of the Fair Market Value of the Unvested Shares, at the time they cease to be Unvested Shares, over the Purchase Price for such Shares. Purchaser represents that Purchaser has consulted any tax advisers Purchaser deems advisable in connection with Purchaser’s purchase of the Shares and the filing of the election under Section 83(b) and similar tax provisions. A form of Election under Section 83(b) is attached hereto as Exhibit A for reference. BY PROVIDING THE FORM OF ELECTION, THE COMPANY DOES NOT THEREBY UNDERTAKE TO FILE THE ELECTION FOR PURCHASER, WHICH OBLIGATION TO FILE SHALL REMAIN SOLELY WITH PURCHASER.

 

5.2           “Fair Market Value”. For the purposes of this Agreement Fair Market Value shall mean the average closing price of the Company’s Common Stock on the principal trading market for the Common Stock during the thirty (30) trading days immediately preceding the date upon which the Fair Market Value is to be determined.

 

6.            GENERAL PROVISIONS.

 

6.1           Successors and Assigns. The Company may assign any of its rights under this Agreement, including its rights to purchase Shares under the Repurchase Option. Neither Purchaser, nor any of Purchaser’s successors and assigns, may assign, whether voluntarily or by operation of law, any of its rights and obligations under this Agreement, except with the prior written consent of the Company. This Agreement shall be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Agreement will be binding upon Purchaser and Purchaser’s heirs, executors, administrators, legal representatives, successors and assigns.

 

-5-

 

 

6.2           Notices. Any and all notices required or permitted to be given to a party pursuant to the provisions of this Agreement will be in writing and will be effective and deemed to provide such party sufficient notice under this Agreement on the earliest of the following: (a) at the time of personal delivery, if delivery is in person; (b) one (1) business day after deposit with an express overnight courier for United States deliveries, or two (2) business days after such deposit for deliveries outside of the United States, with proof of delivery from the courier requested; or (c) three (3) business days after deposit in the United States mail by certified mail (return receipt requested) for United States deliveries. All notices for delivery outside the United States will be sent by express courier. All notices not delivered personally will be sent with postage and/or other charges prepaid and properly addressed to the party to be notified at the address set forth below the signature lines of this Agreement, or at such other address as such other party may designate by one of the indicated means of notice herein to the other parties hereto. Notices to the Company will be marked “Attention: Secretary.”

 

6.3           Further Assurances. The parties agree to execute such further documents and instruments and to take such further actions as may be reasonably necessary to carry out the purposes and intent of this Agreement.

 

6.4           Entire Agreement. This Agreement, together with all Exhibits hereto, constitute the entire agreement and understanding of the parties with respect to the subject matter of this Agreement, and supersede all prior understandings and agreements, between the parties hereto with respect to the specific subject matter hereof.

 

6.5           Severability. If any provision of this Agreement is determined by any court or arbitrator of competent jurisdiction to be invalid, illegal or unenforceable in any respect, such provision will be enforced to the maximum extent possible given the intent of the parties hereto. If such clause or provision cannot be so enforced, such provision shall be stricken from this Agreement and the remainder of this Agreement shall be enforced as if such invalid, illegal or unenforceable clause or provision had (to the extent not enforceable) never been contained in this Agreement. Notwithstanding the forgoing, if the value of this Agreement based upon the substantial benefit of the bargain for any party is materially impaired, which determination as made by the presiding court or arbitrator of competent jurisdiction shall be binding, then both parties agree to substitute such provision(s) through good faith negotiations.

 

6.6           Execution. This Agreement may be entered into in two or more counterparts, each of which shall be deemed an original and all of which shall constitute one and the same agreement. This Agreement may be executed and delivered by facsimile and, upon such delivery, the facsimile signature will be deemed to have the same effect as if the original signature had been delivered to the other party.

 

IN WITNESS WHEREOF, the parties have executed this Restricted Stock Agreement, as of the date first set forth above.

 

IPSIDY INC.   PURCHASER
     
By: /s/Stuart Stoller   /s/Philip Beck
    (Signature)
STUART STOLLER, CFO   PHILIP BECK
(Please print name and title)   (Please print name)
Address:   Address:
780 Long Beach Boulevard   188 Fairway Road
Long Beach, New York 11561   Lido Beach, NY 11561

  

-6-

 

 

EXHIBIT A

 

ELECTION UNDER SECTION 83(b)
OF THE INTERNAL REVENUE CODE

 

The undersigned Taxpayer hereby elects, pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, to include the excess, if any, of the fair market value of the property described below at the time of transfer over the amount paid for such property, as compensation for services in the calculation of regular gross income.

 

1. TAXPAYER’S NAME:  
  TAXPAYER’S ADDRESS:  
     
  SOCIAL SECURITY NUMBER:  

 

2.The property with respect to which the election is made is described as follows: _______ shares of Common Stock of Ipsidy Inc.., a Delaware corporation (the “Company”) which were transferred pursuant to an Incentive Restricted Stock Agreement entered into by Taxpayer and the Company, which is Taxpayer’s employer or the corporation for whom the Taxpayer performs services.

 

3.The date on which the shares were transferred pursuant to the purchase of the shares was ____________________, 2017 and this election is made for calendar year 2017.

 

4.The shares received are subject to the following restrictions: The Company may repurchase all or a portion of the shares for an aggregate purchase price of $1 under certain conditions at the time of Taxpayer’s termination of employment or services, or Taxpayer’s failure to satisfy certain specified performance conditions.

 

5.The fair market value of the shares (without regard to restrictions other than restrictions which by their terms will never lapse) was $________ per share X _________ shares = $______ at the time of purchase.

 

6.The amount paid for such shares by Taxpayer was $________ per share x _______ shares = $_______.

 

7.The Taxpayer has submitted a copy of this statement to the Company.

 

8.The amount to include in gross income is $______________. [The result of the amount reported in Item 5 minus the amount reported in Item 6.]

 

THIS ELECTION MUST BE FILED WITH THE INTERNAL REVENUE SERVICE (“IRS”), AT THE OFFICE WHERE THE TAXPAYER FILES ANNUAL INCOME TAX RETURNS, WITHIN 30 DAYS AFTER THE DATE OF TRANSFER OF THE SHARES, AND MUST ALSO BE FILED WITH THE TAXPAYER’S INCOME TAX RETURNS FOR THE CALENDAR YEAR. THE ELECTION CANNOT BE REVOKED WITHOUT THE CONSENT OF THE IRS.

Dated:      
    Taxpayer’s Signature

 

-7-


Exhibit 10.48

 

IPSIDY INC.

 

RESTRICTED STOCK AGREEMENT

 

This Restricted Stock Agreement (the “Agreement”) is made and entered into as of September 29, 2017 (the “Effective Date”) by and between Ipsidy Inc., a Delaware corporation (the “Company”), and the purchaser named below (the “Purchaser”).

 

Name of Purchaser  Total Number of Shares   Purchase Price Per Share   Total Purchase Price 
Stuart Stoller   5,000,000   $0.0001   $500.00 

 

1.             PURCHASE OF SHARES.

 

1.1       Purchase of Shares. On the Effective Date and subject to the terms and conditions of this Agreement, Purchaser hereby purchases from the Company, and the Company hereby sells to Purchaser, the Total Number of Shares set forth above (the “Shares”) of the Company’s Common Stock, $0.0001 par value per share, at the Purchase Price Per Share as set forth above (the “Purchase Price Per Share”) for a Total Purchase Price as set forth above (the “Purchase Price”). As used in this Agreement, the term “Shares” includes the Shares purchased under this Agreement and all securities received (a) in replacement of the Shares, (b) as a result of stock dividends or stock splits with respect to the Shares, and (c) in replacement of the Shares in a merger, recapitalization, reorganization or similar corporate transaction.

 

1.2       Payment. Company hereby agrees to make payment of the Purchase Price on behalf of Purchaser by way of bonus payment, receipt of which is acknowledged by the Company.

 

2.             COMPANY’S REPURCHASE OPTION FOR UNVESTED SHARES. The Company, or its assignee, shall have the option to repurchase all or a portion of the Purchaser’s Unvested Shares (as defined below) on the terms and conditions set forth in this Section (the “Repurchase Option”) in the event of Purchaser’s termination for any reason whatsoever except in the event of Termination Upon Change of Control (as defined in the Executive Retention Agreement entered into between Company and Purchaser on the date hereof (“Retention Agreement”).

 

2.1       Termination and Termination Date. In case of any dispute as to whether Purchaser is terminated, the Board of Directors of the Company or any Compensation Committee of the Board if such then exists (the “Board”) shall have discretion to determine whether Purchaser has been terminated and the effective date of such termination (the “Termination Date”).

 

2.2       Vested and Unvested Shares. Shares that are vested pursuant to the schedule set forth in this Section 2.2 are “Vested Shares. Shares that are not vested pursuant to such schedule are Unvested Shares.

 

2.2.1        Vesting of Shares. On the Effective Date all of the Shares will be Unvested Shares (the “Unvested Shares”). If Purchaser has continuously provided services to the Company (which shall include for this purpose any subsidiary or parent of the Company), whether as an employee, director, officer or consultant at all times from the Effective Date to the date upon which any of the applicable “Performance Goals” set forth in the schedule below (the “Performance Based Vesting Schedule”) are achieved (such date the “Performance Date”), the “Number of Unvested Shares Becoming Vested Shares” on such Performance Date shall become Vested Shares upon written certification by the Board that the corresponding “Performance Goal” as set forth in the Performance Based Vesting Schedule have been satisfied; provided that such Performance Date occurs on or prior to the last day of the applicable “Performance Period” specified in the Performance Based Vesting Schedule. The Board shall make all such determinations with respect to the achievement and timing of the Performance Goal within the applicable Performance Period. Notwithstanding the foregoing, any Unvested Shares that do not become Vested Shares within the applicable Performance Period shall be forfeited and may be repurchased pursuant to Section 2.3 hereof.

 

-1

 

 

Performance Based Vesting Schedule

 

A.       Performance Goal

 

(1) the occurrence of a Change of Control, (as defined below); OR

 

(2) the filing of Company’s Annual Report on Form 10K in any year, which Report shows that the Company has achieved Adjusted EBITDA for the year, as reported therein, which is not less $10,000,000; OR

 

(3) the Company’s shares becoming listed on a national securities exchange AND (x) if the Board determines that additional equity funding is required, the Company’s closing (whether at the time of listing or subsequent thereto) of a public offering of its equity, raising not less than $10,000,000 in gross proceeds in the aggregate, AND (y) the Company achieving a valuation of not less than $125,000,000 which shall be satisfied either by the closing of the aforementioned public offering with an offering price which equates to a valuation of the Company, which is not less than $125,000,000; or the Company’s shares achieving a closing price on such exchange on 10 trading days out of a period of 30 days, which when multiplied by the number of issued and outstanding shares of Common Stock which are so listed at such time equate to a market capitalization of the Company of not less than $125,000,000; OR

 

(4) the filing of an Annual Report on Form 10K, or a Quarterly Report on Form 10Q, showing that the Company has generated total revenue of not less than $20,000,000 during the 12 month period ending with the period to which the relevant report relates. If such conditions are fulfilled, or waived by the Board, the above bonus shall be payable with the next payroll following the occurrence of the relevant event, subject to all applicable deductions required by law.

 

“Change of Control” shall mean (1) the Company is party to a merger or consolidation, or series of related transactions, which results in the voting securities of the Company outstanding immediately prior thereto failing to continue to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity), directly or indirectly, at least fifty (50%) percent of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; OR (2) the sale or disposition of all or substantially all of the Company’s assets, or consummation of any transaction, or series of related transactions, having similar effect (other than to a subsidiary of the Company)

 

B.            Expiration Date of Performance Period: The Termination Date

C.            Number of Unvested Shares Becoming Vested Shares: 5,000,000

 

If the number of outstanding common shares is changed by a stock dividend, recapitalization, stock split, reverse stock split, subdivision, combination, reclassification or similar change in the capital structure of the Company, without consideration, then the number of Shares subject to this Agreement, the number of Shares, and all other performance criteria set forth in this Section 2.2.1 will be equitably and proportionately adjusted, subject to any required action by the Board or the stockholders of the Company and compliance with applicable securities laws; provided that fractions of a Share will not be issued but will either be replaced by a cash payment equal to the Fair Market Value (as defined below) of such fraction of a Share or will be rounded up to the nearest whole Share, as determined by the Board.

 

-2

 

 

2.3 Exercise of Repurchase Option. At any time within ninety (90) days after the Purchaser’s Termination Date or the Expiration Date of the Performance Period, the Company, or its assignee, shall repurchase any or all the Purchaser’s Unvested Shares by giving Purchaser written notice of exercise of the Repurchase Option, specifying the number of Unvested Shares to be repurchased. Such Unvested Shares shall be repurchased at the price of $1 in the aggregate (the “Repurchase Price”).

 

2.4 Right of Termination Unaffected. Nothing in this Agreement shall be construed to limit or otherwise affect in any manner whatsoever the right or power of the Company (or any Parent or Subsidiary of the Company) to terminate Purchaser’s employment or other relationship with Company (or the Parent or Subsidiary of the Company) at any time, for any reason or no reason, with or without cause.

 

3.            REPRESENTATIONS AND WARRANTIES OF PURCHASER. Purchaser represents and warrants to the Company as follows.

 

3.2       Access to Information. Purchaser has had access to all information regarding the Company and its present and prospective business, assets, liabilities and financial condition that Purchaser reasonably considers important in making the decision to purchase the Shares, and Purchaser has had ample opportunity to ask questions of the Company’s representatives concerning such matters and this investment.

 

3.3       Understanding of Risks. Purchaser is fully aware of: (a) the highly speculative nature of the investment in the Shares; (b) the financial hazards involved; (c) the lack of liquidity of the Shares and the restrictions on transferability of the Shares (e.g., that Purchaser may not be able to sell or dispose of the Shares or use them as collateral for loans); (d) the qualifications and backgrounds of the management of the Company; and (e) the tax consequences of investment in the Shares.

 

3.4       Purchase for Own Account for Investment. Purchaser is purchasing the Shares for Purchaser’s own account for investment purposes only and not with a view to, or for sale in connection with, a distribution of the Shares within the meaning of the Securities Act. Purchaser has no present intention of selling or otherwise disposing of all or any portion of the Shares and no one other than Purchaser has any beneficial ownership of any of the Shares.

 

3.5       No General Solicitation. At no time was Purchaser presented with or solicited by any publicly issued or circulated newspaper, mail, radio, television or other form of general advertising or solicitation in connection with the offer, sale and purchase of the Shares.

 

3.6       SEC Rule 144. Purchaser has been advised that SEC Rule 144 promulgated under the Securities Act, which permits certain limited sales of unregistered securities, may be available with respect to the Shares and, in any event, requires that the Shares be held for a minimum of six (6) months, and in certain cases one (1) year, after they have been purchased and paid for (within the meaning of Rule 144). Purchaser understands that Rule 144 may indefinitely restrict transfer of the Shares so long as Purchaser remains an “affiliate” of the Company or if “current public information” about the Company (as defined in Rule 144) is not publicly available.

 

4.             ADDITIONAL RESTRICTIONS UPON SHARE OWNERSHIP OR TRANSFER.

 

4.1       Rights as a Stockholder. Subject to the terms and conditions of this Agreement, Purchaser will have all of the rights of a stockholder of the Company with respect to the Shares from and after the date that Shares are issued to Purchaser until such time as Purchaser disposes of the Shares or the Company and/or its assignee(s) exercise(s) the Repurchase Option except the right to receive cash distributions or dividends, which to the extent the same are declared shall be held in escrow by the Company and shall only be paid if and to the extent that the Shares become Vested Shares. Upon exercise of the Repurchase Option, Purchaser will have no further rights as a holder of the Shares so purchased upon such exercise, other than the right to receive payment for the Shares so purchased in accordance with the provisions of this Agreement.

 

-3

 

 

4.2       Legends. Unless and until the Shares become Vested Shares and are registered under the Securities Act, all certificates representing the Shares and any certificates subsequently issued in substitution therefor and any certificate for any securities issued pursuant to any stock split, share reclassification, stock dividend or other similar capital event shall bear legends in substantially the following form:

 

THESE SECURITIES ARE SUBJECT TO A RESTRICTED STOCK AGREEMENT BETWEEN THE STOCKHOLDER AND THE COMPANY WHICH CONTAINS RESTRICTIONS ON TRANSFER AND HAVE NOT BEEN REGISTERED OR OTHERWISE QUALIFIED UNDER THE SECURITIES ACT OF 1933 (THE 'SECURITIES ACT') OR UNDER THE APPLICABLE OR SECURITIES LAWS OF ANY STATE. NEITHER THESE SECURITIES NOR ANY INTEREST THEREIN MAY BE SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF WITHOUT THE CONSENT OF THE COMPANY AND IN THE ABSENCE OF REGISTRATION UNDER THE SECURITIES ACT OR ANY APPLICABLE SECURITIES LAWS OF ANY STATE, UNLESS PURSUANT TO EXEMPTIONS THEREFROM.

 

and/or such other legend or legends as the Company and its counsel deem necessary or appropriate. Appropriate stop transfer instructions with respect to the Shares have been or may be placed with the Company's transfer agent.

 

4.3       Encumbrances on Shares. Purchaser may not grant a lien or security interest in, or pledge, hypothecate or encumber, any Unvested Shares.

 

4.4       Restrictions on Transfers. Unvested Shares may not be sold or otherwise transferred by Purchaser without the Company’s prior written consent. Notwithstanding the foregoing, Purchaser shall be able to transfer the Shares, whether or not Vested Shares, for bona fide estate planning purposes to a person or to an entity that constitutes an Authorized Transferee. Subject to Company’s insider trading and other related policies, Purchaser hereby agrees that Purchaser shall make no disposition of the Shares (other than as permitted by this Agreement) unless and until:

 

(a)       Purchaser shall have notified the Company of the proposed disposition and provided a written summary of the terms and conditions of the proposed disposition;

 

(b)       Purchaser shall have complied with all requirements of this Agreement applicable to the disposition of the Shares, including the Repurchase Option; and

 

(c)       Purchaser shall have provided the Company with written assurances, in form and substance satisfactory to counsel for the Company, that (i) the proposed disposition does not require registration of the Shares under the Securities Act or under any state securities laws, and (ii) all appropriate actions necessary for compliance with the registration and qualification requirements of the Securities Act and any state securities laws, or of any exemption from registration or qualification, available thereunder (including Rule 144) have been taken.

 

Each person (other than the Company) to whom the Shares are transferred by means of one of the permitted transfers specified in this Agreement must, as a condition precedent to the validity of such transfer, acknowledge in writing to the Company that such person is bound by the provisions of this Agreement and that the transferred Shares are subject to the Repurchase Option granted hereunder, to the same extent such Shares would be so subject if retained by the Purchaser or otherwise determined by the Board.

 

-4

 

 

4.5       Stop-transfer Orders. Purchaser understands and agrees that to ensure compliance with the restrictions imposed by this Agreement, the Company may issue appropriate “stop-transfer” instructions to its transfer agent. The Company will not be required (a) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or (b) to treat as owner of such Shares, or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares have been so transferred.

 

5.            TAX WITHOLDING AND TAX CONSEQUENCES. The Company may withhold federal, state, local and foreign taxes as required and permitted by applicable law and is authorized to withhold from Shares otherwise deliverable to Purchaser upon vesting that number of Shares having a Fair Market Value determined as of the date of withholding equal to the minimum amount required to be withheld. PURCHASER UNDERSTANDS THAT PURCHASER MAY SUFFER ADVERSE TAX CONSEQUENCES AS A RESULT OF PURCHASER’S PURCHASE OR DISPOSITION OF THE SHARES. PURCHASER REPRESENTS (a) THAT PURCHASER HAS CONSULTED WITH ANY TAX ADVISER THAT PURCHASER DEEMS ADVISABLE IN CONNECTION WITH THE PURCHASE OR DISPOSITION OF THE SHARES AND (b) THAT PURCHASER IS NOT RELYING ON THE COMPANY FOR ANY TAX ADVICE.

 

5.1       Section 83(b) Election. Purchaser hereby acknowledges that Purchaser has been informed that, with respect to Unvested Shares, unless an election is filed by Purchaser with the Internal Revenue Service (and, if necessary, the proper state taxing authorities) within 30 days after the purchase of the Shares electing, pursuant to Section 83(b) of the Internal Revenue Code (and similar state tax provisions, if applicable), to be taxed currently on any difference between the Purchase Price of the Unvested Shares and their Fair Market Value on the date of purchase, there will be a recognition of taxable income to Purchaser, measured by the excess, if any, of the Fair Market Value of the Unvested Shares, at the time they cease to be Unvested Shares, over the Purchase Price for such Shares. Purchaser represents that Purchaser has consulted any tax advisers Purchaser deems advisable in connection with Purchaser’s purchase of the Shares and the filing of the election under Section 83(b) and similar tax provisions. A form of Election under Section 83(b) is attached hereto as Exhibit A for reference. BY PROVIDING THE FORM OF ELECTION, THE COMPANY DOES NOT THEREBY UNDERTAKE TO FILE THE ELECTION FOR PURCHASER, WHICH OBLIGATION TO FILE SHALL REMAIN SOLELY WITH PURCHASER.

 

5.2       “Fair Market Value”. For the purposes of this Agreement Fair Market Value shall mean the average closing price of the Company’s Common Stock on the principal trading market for the Common Stock during the thirty (30) trading days immediately preceding the date upon which the Fair Market Value is to be determined.

 

6.            GENERAL PROVISIONS.

 

6.1       Successors and Assigns. The Company may assign any of its rights under this Agreement, including its rights to purchase Shares under the Repurchase Option. Neither Purchaser, nor any of Purchaser’s successors and assigns, may assign, whether voluntarily or by operation of law, any of its rights and obligations under this Agreement, except with the prior written consent of the Company. This Agreement shall be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Agreement will be binding upon Purchaser and Purchaser’s heirs, executors, administrators, legal representatives, successors and assigns.

 

-5

 

 

6.2       Notices. Any and all notices required or permitted to be given to a party pursuant to the provisions of this Agreement will be in writing and will be effective and deemed to provide such party sufficient notice under this Agreement on the earliest of the following: (a) at the time of personal delivery, if delivery is in person; (b) one (1) business day after deposit with an express overnight courier for United States deliveries, or two (2) business days after such deposit for deliveries outside of the United States, with proof of delivery from the courier requested; or (c) three (3) business days after deposit in the United States mail by certified mail (return receipt requested) for United States deliveries. All notices for delivery outside the United States will be sent by express courier. All notices not delivered personally will be sent with postage and/or other charges prepaid and properly addressed to the party to be notified at the address set forth below the signature lines of this Agreement, or at such other address as such other party may designate by one of the indicated means of notice herein to the other parties hereto. Notices to the Company will be marked “Attention: Secretary.”

 

6.3       Further Assurances. The parties agree to execute such further documents and instruments and to take such further actions as may be reasonably necessary to carry out the purposes and intent of this Agreement.

 

6.4       Entire Agreement. This Agreement, together with all Exhibits hereto, constitute the entire agreement and understanding of the parties with respect to the subject matter of this Agreement, and supersede all prior understandings and agreements, between the parties hereto with respect to the specific subject matter hereof.

 

6.5       Severability. If any provision of this Agreement is determined by any court or arbitrator of competent jurisdiction to be invalid, illegal or unenforceable in any respect, such provision will be enforced to the maximum extent possible given the intent of the parties hereto. If such clause or provision cannot be so enforced, such provision shall be stricken from this Agreement and the remainder of this Agreement shall be enforced as if such invalid, illegal or unenforceable clause or provision had (to the extent not enforceable) never been contained in this Agreement. Notwithstanding the forgoing, if the value of this Agreement based upon the substantial benefit of the bargain for any party is materially impaired, which determination as made by the presiding court or arbitrator of competent jurisdiction shall be binding, then both parties agree to substitute such provision(s) through good faith negotiations.

 

6.6       Execution. This Agreement may be entered into in two or more counterparts, each of which shall be deemed an original and all of which shall constitute one and the same agreement. This Agreement may be executed and delivered by facsimile and, upon such delivery, the facsimile signature will be deemed to have the same effect as if the original signature had been delivered to the other party.

 

IN WITNESS WHEREOF, the parties have executed this Restricted Stock Agreement, as of the date first set forth above.

 

IPSIDY INC.   PURCHASER
         
By: /s/ PHILIP BECK   /s/ STUART STOLLER
      (Signature)
PHILIP BECK, CEO   STUART STOLLER
(Please print name and title)   (Please print name)
Address:   Address:
780 Long Beach Boulevard   28 Elderberry Lane East
Long Beach, New York 11561   Valley Stream, NY 11581

 

-6

 

 

EXHIBIT A

 

ELECTION UNDER SECTION 83(b)
OF THE INTERNAL REVENUE CODE

 

The undersigned Taxpayer hereby elects, pursuant to Section 83(b) of the Internal Revenue Code of 1986, as amended, to include the excess, if any, of the fair market value of the property described below at the time of transfer over the amount paid for such property, as compensation for services in the calculation of regular gross income.

 

1. TAXPAYER’S NAME:  
  TAXPAYER’S ADDRESS:  
     
  SOCIAL SECURITY NUMBER:  

 

2.The property with respect to which the election is made is described as follows: _______ shares of Common Stock of Ipsidy Inc.., a Delaware corporation (the “Company”) which were transferred pursuant to an Incentive Restricted Stock Agreement entered into by Taxpayer and the Company, which is Taxpayer’s employer or the corporation for whom the Taxpayer performs services.

 

3.The date on which the shares were transferred pursuant to the purchase of the shares was ____________________, 2017 and this election is made for calendar year 2017.

 

4.The shares received are subject to the following restrictions: The Company may repurchase all or a portion of the shares for an aggregate purchase price of $1 under certain conditions at the time of Taxpayer’s termination of employment or services, or Taxpayer’s failure to satisfy certain specified performance conditions.

 

5.The fair market value of the shares (without regard to restrictions other than restrictions which by their terms will never lapse) was $________ per share X _________ shares = $______ at the time of purchase.

 

6.The amount paid for such shares by Taxpayer was $________ per share x _______ shares = $_______.

 

7.The Taxpayer has submitted a copy of this statement to the Company.

 

8.The amount to include in gross income is $______________. [The result of the amount reported in Item 5 minus the amount reported in Item 6.]

 

THIS ELECTION MUST BE FILED WITH THE INTERNAL REVENUE SERVICE (“IRS”), AT THE OFFICE WHERE THE TAXPAYER FILES ANNUAL INCOME TAX RETURNS, WITHIN 30 DAYS AFTER THE DATE OF TRANSFER OF THE SHARES, AND MUST ALSO BE FILED WITH THE TAXPAYER’S INCOME TAX RETURNS FOR THE CALENDAR YEAR. THE ELECTION CANNOT BE REVOKED WITHOUT THE CONSENT OF THE IRS.

Dated:      
    Taxpayer’s Signature

 

-7-


Exhibit 31.1 

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

 

I, Philip Beck, Chairman of the Board of Directors, Chief Executive Officer and President certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Ipsidy Inc;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant) and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial data information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: November 13, 2017 /s/Philip Beck
  Philip Beck
 

Chairman of the Board of Directors,

Chief Executive Officer and President

(Principal Executive Officer)

 

 


 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

 

I, Stuart Stoller Chief Financial Officer, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Ipsidy Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant) and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial data information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: November 13, 2017 /s/ Stuart Stoller
 

Stuart Stoller

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 


 

Exhibit 32.1 

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Ipsidy Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2017 as filed with the Securities and Exchange Commission (the “Report”), I, Philip Beck, Chairman of the Board of Directors, Chief Executive Officer and President of the Company, and, Stuart Stoller, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

  /s/ Philip Beck
  Philip Beck, Chairman of the Board of Directors, Chief Executive Officer and President
  (principal executive officer)

 

November 13, 2017 /s/ Stuart Stoller
  Stuart Stoller, Chief Financial Officer
  (principal financial and accounting officer)

 

 


idgs-20170930.xml
Attachment: XBRL INSTANCE FILE


idgs-20170930.xsd
Attachment: XBRL SCHEMA FILE


idgs-20170930_cal.xml
Attachment: XBRL CALCULATION FILE


idgs-20170930_def.xml
Attachment: XBRL DEFINITION FILE


idgs-20170930_lab.xml
Attachment: XBRL LABEL FILE


idgs-20170930_pre.xml
Attachment: XBRL PRESENTATION FILE